{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Setup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import os\n",
    "from langchain.document_loaders import PyPDFLoader, UnstructuredPDFLoader, PyPDFium2Loader\n",
    "from langchain.document_loaders import PyPDFDirectoryLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from pathlib import Path\n",
    "import random\n",
    "\n",
    "## Input data directory\n",
    "data_dir = \"cureus\"\n",
    "inputdirectory = Path(f\"./data_input/{data_dir}\")\n",
    "## This is where the output csv files will be written\n",
    "out_dir = data_dir\n",
    "outputdirectory = Path(f\"./data_output/{out_dir}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load Documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 50%|██████████████████████▌                      | 1/2 [01:37<01:37, 97.80s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of chunks =  135916\n",
      "The authors declare no conflict of interest.\n",
      "\n",
      "4 8 2022 9 2022 4 8 2022 11 9 e00181-2221 3 2022 19 7 2022 Copyright © 2022 Palmieri et al. 2022 Palmieri et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.\n",
      "\n",
      "ABSTRACT\n"
     ]
    }
   ],
   "source": [
    "## Dir PDF Loader\n",
    "# loader = PyPDFDirectoryLoader(inputdirectory)\n",
    "## File Loader\n",
    "# loader = PyPDFLoader(\"./data/MedicalDocuments/orf-path_health-n1.pdf\")\n",
    "loader = DirectoryLoader(inputdirectory, show_progress=True)\n",
    "documents = loader.load()\n",
    "\n",
    "splitter = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=500,\n",
    "    chunk_overlap=50,\n",
    "    length_function=len,\n",
    "    is_separator_regex=False,\n",
    ")\n",
    "\n",
    "pages = splitter.split_documents(documents)\n",
    "print(\"Number of chunks = \", len(pages))\n",
    "print(pages[3].page_content)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create a dataframe of all the chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(135916, 3)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>source</th>\n",
       "      <th>chunk_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td># File: PMC9476978.txt\\n\\n==== Front Microbiol...</td>\n",
       "      <td>data_input/cureus/op1000file.txt</td>\n",
       "      <td>e291fbfbdf6a482391de9bc015c8e89b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>35924938 00181-22 10.1128/mra.00181-22 mra.001...</td>\n",
       "      <td>data_input/cureus/op1000file.txt</td>\n",
       "      <td>f582a51c2c1b4ddc88eea1014faba83e</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Udriet Pauline a https://orcid.org/0000-0002-3...</td>\n",
       "      <td>data_input/cureus/op1000file.txt</td>\n",
       "      <td>d3736d3c22874f41bfe914c4b02616f1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>The authors declare no conflict of interest.\\n...</td>\n",
       "      <td>data_input/cureus/op1000file.txt</td>\n",
       "      <td>e60d2deaaf254247b115b7dffbea2bd9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ABSTRACT\\n\\nHere, we report the complete genom...</td>\n",
       "      <td>data_input/cureus/op1000file.txt</td>\n",
       "      <td>52c4f6c785764df684cf85439640d1c4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                text  \\\n",
       "0  # File: PMC9476978.txt\\n\\n==== Front Microbiol...   \n",
       "1  35924938 00181-22 10.1128/mra.00181-22 mra.001...   \n",
       "2  Udriet Pauline a https://orcid.org/0000-0002-3...   \n",
       "3  The authors declare no conflict of interest.\\n...   \n",
       "4  ABSTRACT\\n\\nHere, we report the complete genom...   \n",
       "\n",
       "                             source                          chunk_id  \n",
       "0  data_input/cureus/op1000file.txt  e291fbfbdf6a482391de9bc015c8e89b  \n",
       "1  data_input/cureus/op1000file.txt  f582a51c2c1b4ddc88eea1014faba83e  \n",
       "2  data_input/cureus/op1000file.txt  d3736d3c22874f41bfe914c4b02616f1  \n",
       "3  data_input/cureus/op1000file.txt  e60d2deaaf254247b115b7dffbea2bd9  \n",
       "4  data_input/cureus/op1000file.txt  52c4f6c785764df684cf85439640d1c4  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from helpers.df_helpers import documents2Dataframe\n",
    "df = documents2Dataframe(pages)\n",
    "print(df.shape)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Extract Concepts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "## This function uses the helpers/prompt function to extract concepts from text\n",
    "from helpers.df_helpers import df2Graph\n",
    "from helpers.df_helpers import graph2Df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to process data in batches\n",
    "def process_batches(dataframe, batch_size=2):\n",
    "    for i in range(0, len(dataframe), batch_size):\n",
    "        yield dataframe.iloc[i:i+batch_size]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "If regenerate is set to True then the dataframes are regenerated and Both the dataframes are written in the csv format so we dont have to calculate them again. \n",
    "\n",
    "        dfne = dataframe of edges\n",
    "\n",
    "        df = dataframe of chunks\n",
    "\n",
    "\n",
    "Else the dataframes are read from the output directory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "ename": "ParserError",
     "evalue": "Error tokenizing data. C error: Expected 5 fields in line 1765, saw 6\n",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mParserError\u001b[0m                               Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[6], line 42\u001b[0m\n\u001b[1;32m     40\u001b[0m         chunk\u001b[38;5;241m.\u001b[39mto_csv(os\u001b[38;5;241m.\u001b[39mpath\u001b[38;5;241m.\u001b[39mjoin(outputdirectory, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mchunks.csv\u001b[39m\u001b[38;5;124m\"\u001b[39m), sep\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m|\u001b[39m\u001b[38;5;124m\"\u001b[39m, mode\u001b[38;5;241m=\u001b[39mmode, index\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mFalse\u001b[39;00m, header\u001b[38;5;241m=\u001b[39m\u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mbool\u001b[39m(chunk_idx))\n\u001b[1;32m     41\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m---> 42\u001b[0m     dfg1 \u001b[38;5;241m=\u001b[39m pd\u001b[38;5;241m.\u001b[39mread_csv(os\u001b[38;5;241m.\u001b[39mpath\u001b[38;5;241m.\u001b[39mjoin(outputdirectory, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mgraph.csv\u001b[39m\u001b[38;5;124m\"\u001b[39m), sep\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m|\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     44\u001b[0m dfg1 \u001b[38;5;241m=\u001b[39m pd\u001b[38;5;241m.\u001b[39mread_csv(os\u001b[38;5;241m.\u001b[39mpath\u001b[38;5;241m.\u001b[39mjoin(outputdirectory, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mgraph.csv\u001b[39m\u001b[38;5;124m\"\u001b[39m), sep\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m|\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     45\u001b[0m dfg1\u001b[38;5;241m.\u001b[39mreplace(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m\"\u001b[39m, np\u001b[38;5;241m.\u001b[39mnan, inplace\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m)\n",
      "File \u001b[0;32m~/miniconda3/lib/python3.11/site-packages/pandas/io/parsers/readers.py:1026\u001b[0m, in \u001b[0;36mread_csv\u001b[0;34m(filepath_or_buffer, sep, delimiter, header, names, index_col, usecols, dtype, engine, converters, true_values, false_values, skipinitialspace, skiprows, skipfooter, nrows, na_values, keep_default_na, na_filter, verbose, skip_blank_lines, parse_dates, infer_datetime_format, keep_date_col, date_parser, date_format, dayfirst, cache_dates, iterator, chunksize, compression, thousands, decimal, lineterminator, quotechar, quoting, doublequote, escapechar, comment, encoding, encoding_errors, dialect, on_bad_lines, delim_whitespace, low_memory, memory_map, float_precision, storage_options, dtype_backend)\u001b[0m\n\u001b[1;32m   1013\u001b[0m kwds_defaults \u001b[38;5;241m=\u001b[39m _refine_defaults_read(\n\u001b[1;32m   1014\u001b[0m     dialect,\n\u001b[1;32m   1015\u001b[0m     delimiter,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1022\u001b[0m     dtype_backend\u001b[38;5;241m=\u001b[39mdtype_backend,\n\u001b[1;32m   1023\u001b[0m )\n\u001b[1;32m   1024\u001b[0m kwds\u001b[38;5;241m.\u001b[39mupdate(kwds_defaults)\n\u001b[0;32m-> 1026\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m _read(filepath_or_buffer, kwds)\n",
      "File \u001b[0;32m~/miniconda3/lib/python3.11/site-packages/pandas/io/parsers/readers.py:626\u001b[0m, in \u001b[0;36m_read\u001b[0;34m(filepath_or_buffer, kwds)\u001b[0m\n\u001b[1;32m    623\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m parser\n\u001b[1;32m    625\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m parser:\n\u001b[0;32m--> 626\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m parser\u001b[38;5;241m.\u001b[39mread(nrows)\n",
      "File \u001b[0;32m~/miniconda3/lib/python3.11/site-packages/pandas/io/parsers/readers.py:1923\u001b[0m, in \u001b[0;36mTextFileReader.read\u001b[0;34m(self, nrows)\u001b[0m\n\u001b[1;32m   1916\u001b[0m nrows \u001b[38;5;241m=\u001b[39m validate_integer(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mnrows\u001b[39m\u001b[38;5;124m\"\u001b[39m, nrows)\n\u001b[1;32m   1917\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1918\u001b[0m     \u001b[38;5;66;03m# error: \"ParserBase\" has no attribute \"read\"\u001b[39;00m\n\u001b[1;32m   1919\u001b[0m     (\n\u001b[1;32m   1920\u001b[0m         index,\n\u001b[1;32m   1921\u001b[0m         columns,\n\u001b[1;32m   1922\u001b[0m         col_dict,\n\u001b[0;32m-> 1923\u001b[0m     ) \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_engine\u001b[38;5;241m.\u001b[39mread(  \u001b[38;5;66;03m# type: ignore[attr-defined]\u001b[39;00m\n\u001b[1;32m   1924\u001b[0m         nrows\n\u001b[1;32m   1925\u001b[0m     )\n\u001b[1;32m   1926\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m:\n\u001b[1;32m   1927\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mclose()\n",
      "File \u001b[0;32m~/miniconda3/lib/python3.11/site-packages/pandas/io/parsers/c_parser_wrapper.py:234\u001b[0m, in \u001b[0;36mCParserWrapper.read\u001b[0;34m(self, nrows)\u001b[0m\n\u001b[1;32m    232\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    233\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mlow_memory:\n\u001b[0;32m--> 234\u001b[0m         chunks \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_reader\u001b[38;5;241m.\u001b[39mread_low_memory(nrows)\n\u001b[1;32m    235\u001b[0m         \u001b[38;5;66;03m# destructive to chunks\u001b[39;00m\n\u001b[1;32m    236\u001b[0m         data \u001b[38;5;241m=\u001b[39m _concatenate_chunks(chunks)\n",
      "File \u001b[0;32mparsers.pyx:838\u001b[0m, in \u001b[0;36mpandas._libs.parsers.TextReader.read_low_memory\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mparsers.pyx:905\u001b[0m, in \u001b[0;36mpandas._libs.parsers.TextReader._read_rows\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mparsers.pyx:874\u001b[0m, in \u001b[0;36mpandas._libs.parsers.TextReader._tokenize_rows\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mparsers.pyx:891\u001b[0m, in \u001b[0;36mpandas._libs.parsers.TextReader._check_tokenize_status\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mparsers.pyx:2061\u001b[0m, in \u001b[0;36mpandas._libs.parsers.raise_parser_error\u001b[0;34m()\u001b[0m\n",
      "\u001b[0;31mParserError\u001b[0m: Error tokenizing data. C error: Expected 5 fields in line 1765, saw 6\n"
     ]
    }
   ],
   "source": [
    "## To regenerate the graph with LLM, set this to True\n",
    "regenerate = False\n",
    "\n",
    "# if regenerate:\n",
    "#     concepts_list = df2Graph(df, model='mistral-openorca:latest')\n",
    "#     dfg1 = graph2Df(concepts_list)\n",
    "#     if not os.path.exists(outputdirectory):\n",
    "#         os.makedirs(outputdirectory)\n",
    "    \n",
    "#     dfg1.to_csv(outputdirectory/\"graph.csv\", sep=\"|\", index=False)\n",
    "#     df.to_csv(outputdirectory/\"chunks.csv\", sep=\"|\", index=False)\n",
    "# else:\n",
    "#     dfg1 = pd.read_csv(outputdirectory/\"graph.csv\", sep=\"|\")\n",
    "\n",
    "# dfg1.replace(\"\", np.nan, inplace=True)\n",
    "# dfg1.dropna(subset=[\"node_1\", \"node_2\", 'edge'], inplace=True)\n",
    "# dfg1['count'] = 4 \n",
    "# ## Increasing the weight of the relation to 4. \n",
    "# ## We will assign the weight of 1 when later the contextual proximity will be calculated.  \n",
    "# print(dfg1.shape)\n",
    "# dfg1.head()\n",
    "\n",
    "if regenerate:\n",
    "    # Assuming df and model are defined elsewhere\n",
    "    chunks = process_batches(df)\n",
    "    first_chunk = True\n",
    "    for chunk_idx, chunk in enumerate(chunks):\n",
    "        concepts_list = df2Graph(chunk, model='mistral-openorca:latest')\n",
    "        dfg1 = pd.DataFrame(concepts_list)\n",
    "        dfg1.replace(\"\", np.nan, inplace=True)\n",
    "        dfg1.dropna(subset=[\"node_1\", \"node_2\", 'edge'], inplace=True)\n",
    "        dfg1['count'] = 4 \n",
    "        \n",
    "        if first_chunk:\n",
    "            mode = 'w'\n",
    "            first_chunk = False\n",
    "        else:\n",
    "            mode = 'a'\n",
    "        dfg1.to_csv(os.path.join(outputdirectory, \"graph.csv\"), sep=\"|\", mode=mode, index=False, header=not bool(chunk_idx))\n",
    "        chunk.to_csv(os.path.join(outputdirectory, \"chunks.csv\"), sep=\"|\", mode=mode, index=False, header=not bool(chunk_idx))\n",
    "else:\n",
    "    dfg1 = pd.read_csv(os.path.join(outputdirectory, \"graph.csv\"), sep=\"|\")\n",
    "\n",
    "dfg1 = pd.read_csv(os.path.join(outputdirectory, \"graph.csv\"), sep=\"|\")\n",
    "dfg1.replace(\"\", np.nan, inplace=True)\n",
    "dfg1.dropna(subset=[\"node_1\", \"node_2\", 'edge'], inplace=True)\n",
    "dfg1['count'] = 4 \n",
    "print(dfg1.shape)\n",
    "print(dfg1.head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(3374, 5)\n",
      "                         node_1  \\\n",
      "0  Cardiovascular disease (CVD)   \n",
      "1                         women   \n",
      "2                         women   \n",
      "3                         women   \n",
      "4                         women   \n",
      "\n",
      "                                              node_2  \\\n",
      "0                         leading cause of mortality   \n",
      "1                                                men   \n",
      "2                      coronary artery disease (CAD)   \n",
      "3  1-year mortality rate after acute myocardial i...   \n",
      "4                                        black women   \n",
      "\n",
      "                                                edge  \\\n",
      "0                      in women in the United States   \n",
      "1                   comparison between men and women   \n",
      "2  having less obstructive but more diffuse coron...   \n",
      "3  higher 1-year mortality rate after acute myoca...   \n",
      "4                 having the highest CAD death rates   \n",
      "\n",
      "                           chunk_id  count  \n",
      "0  3dc851440134402d87573a15088a4351      4  \n",
      "1  51dc59c88fb141e1a0ad643fd6109a21      4  \n",
      "2  51dc59c88fb141e1a0ad643fd6109a21      4  \n",
      "3  51dc59c88fb141e1a0ad643fd6109a21      4  \n",
      "4  51dc59c88fb141e1a0ad643fd6109a21      4  \n"
     ]
    }
   ],
   "source": [
    "dfg1 = pd.read_csv(os.path.join(outputdirectory, \"graph.csv\"), sep=\"|\")\n",
    "dfg1.replace(\"\", np.nan, inplace=True)\n",
    "dfg1.dropna(subset=[\"node_1\", \"node_2\", 'edge'], inplace=True)\n",
    "dfg1['count'] = 4 \n",
    "print(dfg1.shape)\n",
    "print(dfg1.head())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Calculating contextual proximity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>node_1</th>\n",
       "      <th>node_2</th>\n",
       "      <th>chunk_id</th>\n",
       "      <th>count</th>\n",
       "      <th>edge</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>51029</th>\n",
       "      <td>zebrafish and in mice</td>\n",
       "      <td>SIRT1</td>\n",
       "      <td>9508450fd46943c092632c7e026877c4,9508450fd4694...</td>\n",
       "      <td>4</td>\n",
       "      <td>contextual proximity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51038</th>\n",
       "      <td>β blockers</td>\n",
       "      <td>ARBs</td>\n",
       "      <td>a3cb4cf2955a46e6a1149c6b9c9a8c15,a3cb4cf2955a4...</td>\n",
       "      <td>2</td>\n",
       "      <td>contextual proximity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51054</th>\n",
       "      <td>€ 192 billion</td>\n",
       "      <td>CVD</td>\n",
       "      <td>5858afe30c1d44558b8f8632fc6ad382,5858afe30c1d4...</td>\n",
       "      <td>6</td>\n",
       "      <td>contextual proximity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51069</th>\n",
       "      <td>≥ 7.5%</td>\n",
       "      <td>elevated hs-CRP</td>\n",
       "      <td>426fe5b8c62e4adfa880f23ac1d76acc,426fe5b8c62e4...</td>\n",
       "      <td>2</td>\n",
       "      <td>contextual proximity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51081</th>\n",
       "      <td>≥140 and ≥90</td>\n",
       "      <td>AH</td>\n",
       "      <td>c20c2bbc85ba423ebb0a4c64cf758931,c20c2bbc85ba4...</td>\n",
       "      <td>2</td>\n",
       "      <td>contextual proximity</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      node_1           node_2  \\\n",
       "51029  zebrafish and in mice            SIRT1   \n",
       "51038             β blockers             ARBs   \n",
       "51054          € 192 billion              CVD   \n",
       "51069                 ≥ 7.5%  elevated hs-CRP   \n",
       "51081           ≥140 and ≥90               AH   \n",
       "\n",
       "                                                chunk_id  count  \\\n",
       "51029  9508450fd46943c092632c7e026877c4,9508450fd4694...      4   \n",
       "51038  a3cb4cf2955a46e6a1149c6b9c9a8c15,a3cb4cf2955a4...      2   \n",
       "51054  5858afe30c1d44558b8f8632fc6ad382,5858afe30c1d4...      6   \n",
       "51069  426fe5b8c62e4adfa880f23ac1d76acc,426fe5b8c62e4...      2   \n",
       "51081  c20c2bbc85ba423ebb0a4c64cf758931,c20c2bbc85ba4...      2   \n",
       "\n",
       "                       edge  \n",
       "51029  contextual proximity  \n",
       "51038  contextual proximity  \n",
       "51054  contextual proximity  \n",
       "51069  contextual proximity  \n",
       "51081  contextual proximity  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def contextual_proximity(df: pd.DataFrame) -> pd.DataFrame:\n",
    "    ## Melt the dataframe into a list of nodes\n",
    "    dfg_long = pd.melt(\n",
    "        df, id_vars=[\"chunk_id\"], value_vars=[\"node_1\", \"node_2\"], value_name=\"node\"\n",
    "    )\n",
    "    dfg_long.drop(columns=[\"variable\"], inplace=True)\n",
    "    # Self join with chunk id as the key will create a link between terms occuring in the same text chunk.\n",
    "    dfg_wide = pd.merge(dfg_long, dfg_long, on=\"chunk_id\", suffixes=(\"_1\", \"_2\"))\n",
    "    # drop self loops\n",
    "    self_loops_drop = dfg_wide[dfg_wide[\"node_1\"] == dfg_wide[\"node_2\"]].index\n",
    "    dfg2 = dfg_wide.drop(index=self_loops_drop).reset_index(drop=True)\n",
    "    ## Group and count edges.\n",
    "    dfg2 = (\n",
    "        dfg2.groupby([\"node_1\", \"node_2\"])\n",
    "        .agg({\"chunk_id\": [\",\".join, \"count\"]})\n",
    "        .reset_index()\n",
    "    )\n",
    "    dfg2.columns = [\"node_1\", \"node_2\", \"chunk_id\", \"count\"]\n",
    "    dfg2.replace(\"\", np.nan, inplace=True)\n",
    "    dfg2.dropna(subset=[\"node_1\", \"node_2\"], inplace=True)\n",
    "    # Drop edges with 1 count\n",
    "    dfg2 = dfg2[dfg2[\"count\"] != 1]\n",
    "    dfg2[\"edge\"] = \"contextual proximity\"\n",
    "    return dfg2\n",
    "\n",
    "\n",
    "dfg2 = contextual_proximity(dfg1)\n",
    "dfg2.tail()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Merge both the dataframes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>node_1</th>\n",
       "      <th>node_2</th>\n",
       "      <th>chunk_id</th>\n",
       "      <th>edge</th>\n",
       "      <th>count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>marine n-3 fatty acids, fish intake, and the ...</td>\n",
       "      <td>Physicians’ Health Study</td>\n",
       "      <td>c1322d3da33247ada5e8fc7a1034048b,c1322d3da3324...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(1·69–2·63)</td>\n",
       "      <td>2·11</td>\n",
       "      <td>fcfdafc6471042d08b1fe8b96a7be029,fcfdafc647104...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(1·69–2·63)</td>\n",
       "      <td>Hazard ratio</td>\n",
       "      <td>fcfdafc6471042d08b1fe8b96a7be029,fcfdafc647104...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(95% CI)</td>\n",
       "      <td>Author Manuscript</td>\n",
       "      <td>61c8344660df49bdb13316c58314cd72,61c8344660df4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(95% CI)</td>\n",
       "      <td>effect estimate</td>\n",
       "      <td>61c8344660df49bdb13316c58314cd72,61c8344660df4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12865</th>\n",
       "      <td>zebrafish and in mice</td>\n",
       "      <td>SIRT1</td>\n",
       "      <td>9508450fd46943c092632c7e026877c4,9508450fd4694...</td>\n",
       "      <td>observed to regulate blood vessel growth in,co...</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12866</th>\n",
       "      <td>β blockers</td>\n",
       "      <td>ARBs</td>\n",
       "      <td>a3cb4cf2955a46e6a1149c6b9c9a8c15,a3cb4cf2955a4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12867</th>\n",
       "      <td>€ 192 billion</td>\n",
       "      <td>CVD</td>\n",
       "      <td>5858afe30c1d44558b8f8632fc6ad382,5858afe30c1d4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12868</th>\n",
       "      <td>≥ 7.5%</td>\n",
       "      <td>elevated hs-CRP</td>\n",
       "      <td>426fe5b8c62e4adfa880f23ac1d76acc,426fe5b8c62e4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12869</th>\n",
       "      <td>≥140 and ≥90</td>\n",
       "      <td>AH</td>\n",
       "      <td>c20c2bbc85ba423ebb0a4c64cf758931,c20c2bbc85ba4...</td>\n",
       "      <td>contextual proximity</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>12870 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  node_1  \\\n",
       "0       marine n-3 fatty acids, fish intake, and the ...   \n",
       "1                                            (1·69–2·63)   \n",
       "2                                            (1·69–2·63)   \n",
       "3                                               (95% CI)   \n",
       "4                                               (95% CI)   \n",
       "...                                                  ...   \n",
       "12865                              zebrafish and in mice   \n",
       "12866                                         β blockers   \n",
       "12867                                      € 192 billion   \n",
       "12868                                             ≥ 7.5%   \n",
       "12869                                       ≥140 and ≥90   \n",
       "\n",
       "                         node_2  \\\n",
       "0      Physicians’ Health Study   \n",
       "1                          2·11   \n",
       "2                  Hazard ratio   \n",
       "3             Author Manuscript   \n",
       "4               effect estimate   \n",
       "...                         ...   \n",
       "12865                     SIRT1   \n",
       "12866                      ARBs   \n",
       "12867                       CVD   \n",
       "12868           elevated hs-CRP   \n",
       "12869                        AH   \n",
       "\n",
       "                                                chunk_id  \\\n",
       "0      c1322d3da33247ada5e8fc7a1034048b,c1322d3da3324...   \n",
       "1      fcfdafc6471042d08b1fe8b96a7be029,fcfdafc647104...   \n",
       "2      fcfdafc6471042d08b1fe8b96a7be029,fcfdafc647104...   \n",
       "3      61c8344660df49bdb13316c58314cd72,61c8344660df4...   \n",
       "4      61c8344660df49bdb13316c58314cd72,61c8344660df4...   \n",
       "...                                                  ...   \n",
       "12865  9508450fd46943c092632c7e026877c4,9508450fd4694...   \n",
       "12866  a3cb4cf2955a46e6a1149c6b9c9a8c15,a3cb4cf2955a4...   \n",
       "12867  5858afe30c1d44558b8f8632fc6ad382,5858afe30c1d4...   \n",
       "12868  426fe5b8c62e4adfa880f23ac1d76acc,426fe5b8c62e4...   \n",
       "12869  c20c2bbc85ba423ebb0a4c64cf758931,c20c2bbc85ba4...   \n",
       "\n",
       "                                                    edge  count  \n",
       "0                                   contextual proximity      3  \n",
       "1                                   contextual proximity      2  \n",
       "2                                   contextual proximity      2  \n",
       "3                                   contextual proximity      2  \n",
       "4                                   contextual proximity      2  \n",
       "...                                                  ...    ...  \n",
       "12865  observed to regulate blood vessel growth in,co...      8  \n",
       "12866                               contextual proximity      2  \n",
       "12867                               contextual proximity      6  \n",
       "12868                               contextual proximity      2  \n",
       "12869                               contextual proximity      2  \n",
       "\n",
       "[12870 rows x 5 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfg = pd.concat([dfg1, dfg2], axis=0)\n",
    "dfg = (\n",
    "    dfg.groupby([\"node_1\", \"node_2\"])\n",
    "    .agg({\"chunk_id\": \",\".join, \"edge\": ','.join, 'count': 'sum'})\n",
    "    .reset_index()\n",
    ")\n",
    "dfg"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Calculate the NetworkX Graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(4591,)"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nodes = pd.concat([dfg['node_1'], dfg['node_2']], axis=0).unique()\n",
    "nodes.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "G = nx.Graph()\n",
    "\n",
    "## Add nodes to the graph\n",
    "for node in nodes:\n",
    "    G.add_node(\n",
    "        str(node)\n",
    "    )\n",
    "\n",
    "## Add edges to the graph\n",
    "for index, row in dfg.iterrows():\n",
    "    G.add_edge(\n",
    "        str(row[\"node_1\"]),\n",
    "        str(row[\"node_2\"]),\n",
    "        title=row[\"edge\"],\n",
    "        weight=row['count']/4\n",
    "    )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Calculate communities for coloring the nodes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Communities =  686\n",
      "[[' Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2010; 10(24)', 'Filion K, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM'], [' marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.', '(1·69–2·63)', '(95% CI)', '1-year mortality rate after acute myocardial infarction', '1. A varied well-balanced diet', '1.28 (1.15–1.43)', '1.41 (1.26–1.55)', '10% or greater 10-year CVD risk', '10-year ASCVD risk ≥ 7.5%', '10-year and lifetime atherosclerotic cardiovascular disease event risk', '10-year risk for heart disease and stroke assessment', '10-year risk of fatal cardiovascular disease (CVD)', '10479204', '110', '110(8): 1097–1108', '120-129 and <80', '130-139 or 80-89 AH', '1302-31', '133(13)', '138: 1100–12', '13: e0206548', '144 336 43 407 3035 50 (11)', '152: 1490-500.', '153 REVIEW ARTICLE', '15333163', '15495044', '155', '1573-403X/18 $58.00+.00', '15: 359–60', '165', '17135583', '173 (163, 183)', '18160071', '19221219', '1986', '199 (188, 209)', '1993; 88(2):523–33', '1994', '1995; 142(2): 166–75.', '1996–2011†', '1997; 95(11):2591–3', '1st degree AH', '1·14 (1·04–1·25)', '1·17', '1·86 (1·39–2·50)', '2000-2002 early cART era', '2003', '2003-2005 intermediate cART era', '2003; 47:214–20', '2004-2009 10 760 18 (HIV)', '2004; 1:CD003041', '2006-2009 late cART era', '2008; 18(4):283–90', '2009 South African study', '2010', '2010 South African guidelines', '2010-2015 10 760 34 (HIV)', '2010; 104(1):125–34', '2011 effectiveness-based guidelines', '2011 update', '2013 ACC/AHA Guidelines', '2013 ACC/AHA guideline on the assessment of cardiovascular risk', '2013 ACC/AHA lipid guidelines', '2014; 33: 924–30', '2016 European Guidelines on cardiovascular disease pre-vention in clinical practice', '2016 Mar', '2016 Mar 29', '2016; 117: 214–20', '2017', '2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/AphA/ASH/ASPC/NMA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults', '2017 American Heart Association (AHA) Guidelines', '2017; 216: 545–53', '2018', '2018, 14, 153-163', '2018, Vol. 14, No. 3', '20208999', '2030', '222 (211, 233)', '24 768', '24929646', '279 (265, 293)', '27: 1828–36', '2803', '287-92', '28886620', '28931222', '29273597', '29952786', '2nd degree AH', '2·11', '3 weeks', '3. Effects in patients at different levels of cardiovascular risk', '30 Median', '30 minutes to 60 minutes physical activity per day', '31·3% per 100 000 person-years', '32 (suppl 1): S5–20', '32 (suppl 1): S93–S105', '32(10):1235–43', '332(15): 977–82.', '360: 7-22', '37.9 million people living with HIV worldwide', '3776973', '39: 763–816', '4 clinical studies', '4-times increased risk', '47', '49: 228-31', '5% reduction in LDL levels', '5% to 7.5% 10-year ASCVD risk', '50,000 patients', '534,906 individuals', '55(8):636–42', '62% do not use it, rely on a subjective assessment', '7', '70-189 mg/dL', '76 835 participants', '78%', '9 cohorts', '90-92', '910 49 participants', '95% CI', '9·4% rate of sudden cardiac death', '< 25 kg/m', '< 35 inches', '<120 and <80', 'A concept from extracted ontology', 'A healthy diet', 'ACC', 'ACE inhibitors', 'ACE inhibitors, ARBs, β blockers, or mineralocorticoid antagonists', 'AFCAPS/TexCAPS', 'AFCAPS/TexCAPS Research Group', 'AH', 'AH stage 1', 'AH stage 2', 'AHA', 'AHA guidelines', 'AHA/ACC', 'AHA/ACC/HRS guideline', 'AIDS', 'AIDS 2018', 'AIDS 2018; 32 (suppl 1): S93–S105', 'AIDS 2019; 33: 2025–33', 'AIDS Patient Care STDS 2016', 'AMI events', 'ARBs', 'ART', 'ART era', 'ART initiation', 'ART side-effects', 'ART-related mechanisms', 'ART.35,62,77', 'ART.79', 'ASCVD risk factors', 'ASCVD risk score', 'AbdelRazek MA, Gutierrez J, Mampre D, et al.', 'Aboyans V, Ricco JB, Bartelink MEL, et al.', 'Acta Med Croatica 2007; 61(3)', 'Active HIV replication', 'Additional testing (eg, ankle-brachial index)', 'Adjudicated heart failure in HIV-infected and uninfected men and women', 'Affiliation of Iskra A. Nola', 'Affiliation of Sonja Frančula-Zaninović', 'Africa', 'African dyslipidaemia guideline consensus statement', 'After the age of 55', 'Age', 'Age-standardised estimate', 'Ages over 25 years', 'Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)', 'All other studies (appendix p 1)', 'All stroke', 'Alonso A', 'Alonso A, Barnes AE, Guest JL, Shah A, Shao IY , Marconi V .', 'Alonso et al (2019)', 'Alvi et al (2019)', 'Am J Cardiol', 'Am J Cardiol 2000', 'Am J Cardiol 2012;', 'Am J Clin Nutr.', 'Am J Epidemiol', 'Am J Epidemiol.', 'Am J Med', 'Am J Med.', 'American College of Cardiology', 'American College of Cardiology (ACC)/American Heart Association (AHA) atherosclerotic cardiovascular disease (ASCVD) risk score', 'American College of Cardiology/American Heart Association Task Force on Clinical Practice', 'American College of Cardiology/American Heart Association Task Force on Practice Guidelines', 'American College of Obstetrics and Gynecology', 'American Diabetes Association', 'American Diabetes Society', 'American Heart Association', 'American Heart Association (AHA) and European Society of Cardiology (ESC)', 'American Heart Association Nutrition Committee', 'American Heart Association Statement', 'American Journal of Epidemiology', 'Ames dwarf mice', 'Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, Zagreb, Croatia', 'Ankle brachial index', 'Ann Intern Med', 'Annals of Nutr & Metabolism', 'Antioxidant vitamins', 'Antiretroviral therapy', 'Approaches to reducing sudden cardiac death', 'Aravanis C', 'Arch Intern Med', 'Arch Intern Med.', 'Arterial hypertension in Croatia. Results of EH-UH study', 'As in general population with exceptions on interactions of', 'Ascherio A', 'Asia', 'Assess blood pressure at ART initiation', 'Assess overall risk of patients', 'Assessing Cardiovascular Risk and Testing in Type 2 Diabetes', 'Association of human immunodeficiency virus infection and risk of peripheral artery disease', 'Atherosclerosis', 'Atherosclerosis. 2008; 197:12–24. [PubMed: 18160071]', 'Atherosclerotic process', 'Author', 'Author Manuscript', 'Author manuscript', 'Author manuscript; available in PMC 2016 March 01', 'Author manuscript; available in PMC 2022 August 03.', 'Authors', 'Authors of the article', 'Ave Louis Pasteur', 'Ave Louis Pasteur, Boston', 'B Fuhrman, M Aviram', 'BMC Public Health', 'BMI', 'BMJ Open 2017', 'BP', 'Baatiema L', 'Balk E, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J.', 'Baltimore-Washington Cooperative', 'Beckman JA, Duncan MS, Alcorn CW, et al.', 'Beckman et al (2019)', 'Beitz R', 'Benjamin LA, Corbett EL, Connor MD, et al.', 'Bentham Science Publishers', 'Black Africans with HIV infection', 'Blackburn H', 'Blood Pressure', 'Blood pressure < 140/90 mm Hg', 'Blood pressure and vitamin C and fruit and vegetable intake', 'Blood pressure check', 'Blood pressure lowering treatment', 'Blood pressure-lowering treatment', 'Boston University School of Medicine, Boston, MA, USA', 'Boston, MA 02115', 'Both sexes', 'Br J Nutr', 'Br J Nutr. 2010; 104(1):125–34', 'Brigham and Women’s Hospital', 'Brkić Biloš I', 'Broekmans W, Klopping-Ketelaars WAA, Kluft C, van den Berg H, Kok FJ, van Poppel G', 'Bronx Lebanon Hospital Center', 'Buring JE', 'Burkholder GA, Tamhane AR, Salinas JL, et al.', 'Burton A', 'Burton A South Africa: stroke units out of the blue', 'Butter and walnuts', 'Buzina R', 'CAC scoring', 'CAD in women', 'CAROTID INTIMA-MEDIA THICKNESS', 'CD4+ So-Armah et al.', 'CD4+ T-cell depletion', 'CD4+ count-guided interruption of antiretroviral treatment', 'CDC', 'CIMT', 'CKD', 'CLINICAL RISK FACTORS TARGETS AND USES IN RISK ASSESSMENT', 'CMV and aging', 'CR diets', 'CROI', 'CSF/plasma HIV-1 RNA', 'CSF/plasma HIV-1 RNA discordance', 'CV', 'CV outcomes', 'CV prevention', 'CV risk factors such as smoking and physical inactivity', 'CVA', 'CVD', 'CVD Measurable Risk Factors', 'CVD Measurable Risk Factors Current Cardiology Reviews', 'CVD Prevention', 'CVD Prevention measures', 'CVD Risk Protocols', 'CVD capacity (non-invasive, invasive)', 'CVD development', 'CVD events', 'CVD in the European Union', 'CVD increase', 'CVD prevention', 'CVD prevention and treatment', 'CVD prevention guidelines', 'CVD protection', 'CVD rehabilitation program', 'CVD risk', 'CVD risk assessing', 'CVD risk estimate', 'CVD risk factor', 'CVD risk factors', 'CVD risks', 'CVD treatment', 'Calder P.', 'Cameroon', 'Cardiac manifestations', 'Cardiac rehabilitation', 'Cardiology practice', 'Cardiomyocyte senescence', 'Cardiomyocyte size', 'Cardioprotective effect', 'Cardiovascular', 'Cardiovascular Disease', 'Cardiovascular Disease Risk', 'Cardiovascular Disease Risk Factors', 'Cardiovascular Disease in Women: Clinical Perspectives', 'Cardiovascular Diseases (CVD)', 'Cardiovascular Risk', 'Cardiovascular clinical trials', 'Cardiovascular disease', 'Cardiovascular disease prevention, prediction, and risk reduction', 'Cardiovascular disease risk', 'Cardiovascular disease risk calculators', 'Cardiovascular disease risk prediction', 'Cardiovascular disease risk prediction for people living with HIV in sub-Sahara Africa', 'Cardiovascular disease types', 'Cardiovascular medicine', 'Cardiovascular risk', 'Cardiovascular sequelae of preeclampsia/eclampsia', 'Carracedo J', 'Caruso D', 'Cedarbaum E, Ma Y , Scherzer R, et al.', 'Centers for Disease Control and Prevention', 'Cerebral infarction', 'Chamie G, Kwarisiima D, Clark TD, et al.', 'Chan CKY', 'China', 'Chronic Kidney Disease', 'Chylomicrons and VLDL', 'Circ Res', 'Circ Res.', 'Circulation', 'Circulation 2018', 'Circulation. 2009; 114:82–96', 'Classical cardiovascular risk factors', 'Classification of BP and AH', 'Clin Infect Dis 2012; 55: 1550–57.', 'Clin Sci (Lond). 2004; 107(1):1–11. [PubMed: 15132735]', 'Clinical and mechanistic perspectives', 'Cochrane Database Syst Rev', 'Cohort of HIV adults of the AIDS research network (Spain)', 'Cole et al.', 'Collagen content', 'Collins PY', 'Colombo PC', 'Commercial Claims and Encounter', 'Compliance of GPs', 'Components', 'Consider therapy from one of the indicated classes of antihypertensive drugs', 'Constituents of Mediterranean diet', 'Consume non-fat milk products', 'Contributions of HIV , hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women', 'Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Hypertension, Council on Lifestyle and Cardiometabolic Health, and Council on Quality of Care and Outcomes Research', 'Country of the month', 'Covas MI', 'Cross-sectional', 'Curr Cardiol Rep', 'Current Cardiology Reviews', 'Current Cardiology Reviews 2018, 14, 153-163', 'Current Cardiology Reviews, 2018, Vol. 14, No. 3', 'Cytomegalovirus antibody status', 'Cytomegalovirus status', 'D type of distress', 'D.A.S.', 'DALYS', 'DART', 'DBP', 'Data', 'Database', 'Dauchet L, Amouyel P, Hercberg S, Dallongeville J.', 'Delgado-Lista J', 'Developed with the special contribution', 'Diabetes', 'Diabetes Care', 'Diabetes Mellitus', 'Diastolic BP (mmHg)', 'Diastolic Blood Pressure', 'Diastolic blood pressure', 'Diet and lifestyle recommendations revision', 'Diet and lifestyle recommendations revision 2006', 'Diet and reinfarction trial', 'Dietary intake of marine n-3 fatty acids', 'Disparities in cardiovascular care', 'Distribution', 'District hospital level', 'Djordjevic BS', 'Document', 'Donnan GA', 'Dontas AS', 'Drug interactions', 'Drugs and cardiotoxicity', 'Duke Global Health Institute, Duke University, Durham, North Carolina, NC, USA', 'Durand et al (2011)', 'Dyslipidaemia', 'EH-UH study', 'EPIC-Heart study', 'ESC guide-lines', 'ESC guidelines', 'ESC guidelines for CVD prevention', 'ESC strongly endorses', 'EU-ROSPIRE I-IV (including the Republic of Croatia)', 'EU-ROSPIRE III study', 'EUROLIVE study', 'Eat fruits, vegetables, cereals and whole grain products', 'Eat unleavened meat, avoid fried', 'Effect', 'Effect estimate (95% CI)', 'Effect of lovastatin on cardio-vascular resource utilization and', 'Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-52', 'Effectiveness-based guidelines', 'Effects', 'Effects of blood pressure lowering on outcome incidence in hypertension', 'Effects of omega-3 fatty acids', 'El-Sadr WM', 'Electric Study', 'Elevated BP', 'Elevated LDL-C, triglycerides, and non-HDL-C', 'Endogenous estrogens', 'English', 'Era of study', 'Established cardiovascular disease', 'Estimates of risk ratio reduction', 'Eur Heart J 2013; 34: 2159-219', 'Eur Heart J 2018', 'Eur Heart J.', 'Eur J Clin Nutr.', 'Eur J Nutr', 'Europe', 'European Association for Cardiovascular', 'European Cardiology Society (ESC)', 'European Cardiology guidelines', 'European Journal of Preventive Cardiology', 'European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study', 'European Society for Cardiology guidelines', 'European Society for Vascular Surgery (ESVS)', 'European Society of Cardiology (ESC)', 'European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)', 'European Society of Hypertension (ESH)', 'European Stroke Organization', 'European guidelines', 'Extra Virgin Olive Oil', 'FOXO1 overexpression', 'FOXO3a expression', 'Family Physicians', 'Feinstein MJ, Kim JH, Bibangambah P, et al.', 'Feinstein MJ, Steverson AB, Ning H, et al.', 'Female participation', 'Fidanza F', 'Fig. (1). SCORE chart:', 'Fischer B', 'Fish', 'Fish Consumption', 'Fish oils in the care of coronary heart disease patients', 'Flavonoids protect LDL from oxidation and attenuate atherosclerosis', 'Food habits', 'Food rich in saturated fats', 'Foods', 'Frančula-Zaninović and Nola', 'Freiberg et al (CROI 2019, unpublished)', 'French hospital database on HIV', 'Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies', 'Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean', 'Fruit and vegetable intake', 'Fruit and vegetables', 'Fruits, vegetables', 'Fruits/Vegetables', 'Full lipogram recommended', 'Future studies', 'G- α-q overexpression–induced', 'GDM', 'GISSI-Prevention', 'GPs and general internists', 'GPs in Europe', 'Garcia M', 'General population', 'Gerald S Bloomfield, MD', 'Gestational diabetes mellitus', 'Gestational hypertensive disorders', 'Global burden of atherosclerotic cardiovascular disease', 'Global prevalence', 'Global preventive polices. Strategies at European and worldwide level. Online Referencing, http://www.revespcardiol. org/eu/global-preventive-policies-strategies-at/articulo/13125894.', 'Goff DC Jr', 'Gotto AM Jr, Bocuzzi SJ, Cook JR. Effect of lovastatin on cardiovascular resource utilization and', 'Government policies', 'Grady Memorial Hospital, USA', 'Grande S', 'Guidelines', 'Guidelines on cardiovascular disease prevention, prediction, and risk reduction', 'H3Africa AWI-Gen study', 'HDL', 'HDL cholesterol', 'HDL-C < 40 mg/dL', 'HHS Public Access', 'HIV', 'HIV , antiretroviral treatment, hypertension, and stroke', 'HIV Surveillance Database', 'HIV and AIDS', 'HIV and Cardiovascular Disease', 'HIV and cardiovascular disease epidemiology', 'HIV and non-communicable disease services', 'HIV cases', 'HIV cure', 'HIV disease burden', 'HIV infection', 'HIV infection and incidence of cardiovascular diseases', 'HIV management', 'HIV negative', 'HIV negative effect estimate', 'HIV positive', 'HIV positive effect estimate', 'HIV prevalence', 'HIV primary care', 'HIV provider-patient communication', 'HIV sero-positive versus sero-negative individuals', 'HIV specialty clinic', 'HIV specialty clinic in San', 'HIV status', 'HIV viral suppression', 'HIV virus', 'HIV-', 'HIV-1 RNA', 'HIV-1 infected individuals', 'HIV-associated cardiovascular disease', 'HIV-associated cardiovascular disease risk', 'HIV-associated heart failure', 'HIV-associated risk', 'HIV-associated vasculitis', 'HIV-care guidelines', 'HIV-infected individuals', 'HIV-infected patients', 'HIV-infected patients in sub-Saharan Africa', 'HIV-infected veterans', 'HIV-population cohorts are from there', 'HIV-related cardiovascular', 'HIV-related cardiovascular disease', 'HIV-specific risk estimation model', 'HIV/AIDS patient cohort in Taiwan', 'HMG-CoA', 'HT', 'Hallmans G', 'Hambrecht R', 'Harris W, Miller M, Tighe AP, Davidson MH, Schaefer EJ', 'Harris WS', 'Hazard ratio', 'HbA1c cutoff of 5·8%', 'Health Care Center Zagreb', 'Health Care Center Zagreb, Laginjina 16, Zagreb, Croatia', 'Healthy lifestyles', 'Healthy nutrition', 'Heart AIR Force Texas Coronary Atherosclerosis Protection Study', 'Heart Disease', 'Heart Study Collaborators', 'Heart failure', 'Heart failure Hazard ratio', 'Heart failure outcomes', 'Heart of Soweto Study cohort', 'High Blood pressure', 'High risk', 'High-risk populations', 'High-risk strategy', 'Higher amounts of fish', 'Highly Normal BP', 'Hipertensión 2009; 26: 275-9', 'Hospital-based study', 'Howard B', 'Howells DW', 'Hs-CRP > 3.0 mg/dL', 'Hsia J', 'Hu FB', 'Human immunodeficiency virus-infected adults', 'Huxley R', 'Hypercholesterolemia', 'Hypertension', 'Hypertensive Disorders of Pregnancy', 'Hypertriglyceridemia', 'Icahn School of Medicine at Mount Sinai, USA', 'Ideal cardiovascular health and carotid atherosclerosis in a mixed cohort of HIV-infected and uninfected Ugandans', 'Immunosenescence', 'Improved lipids, reduces ROS, endothelial function, platelet function', 'Improvement in cardiac defects observed in some aging models', 'Improvement in cardiovascular disease prevention', 'Improves lipid profiles and BP', 'Improves lipid profiles and BP; reduces ROS', 'Incidence', 'Incidence rate ratio', 'Incident cardiovascular disease', 'Inconsistent results', 'Increased expression of senescence markers and decreased telomere length', 'Increased risk', 'India', 'Institute of Infection and Global Health, University of Liverpool, Liverpool, UK', 'Institution', 'Integrated noncommunicable disease clinic', 'Intensive AH treatment', 'Intervention points', 'Intravenous thrombolysis for stroke and presumed stroke in human immunodeficiency virus-infected adults: a retrospective, multicenter US study', 'Ischaemic stroke', 'J Am Coll Cardiol', 'J Am Coll Cardiol 2019', 'J Am Heart Assoc', 'J Am Heart Assoc 2018', 'J Am Heart Assoc 2019; 8: e012241.', 'J Heart Lung Transplant', 'J Infect Dis', 'J Nutr.', 'J Stroke Cerebrovasc Dis', 'J Stroke Cerebrovasc Dis 2018', 'JACC Heart Fail 2013', 'JAMA 2012 publication', 'JAMA Cardiol 2017', 'Japan EPA Lipid Intervention Study JELIS studies', 'Jelaković B, Zeljković-Vrkić T, Pećin I', 'Jenkins C, Ovbiagele B, Arulogun O, et al.', 'Jenkins C, Ovbiagele B, Arulogun O, et al. Knowledge, attitudes and practices related to stroke in Ghana and Nigeria: A SIREN call to action', 'Kaiser Permanente Southern California', 'Kaku So-Armah, PhD', 'Kamdem F, Mapoure Y , Hamadou B, et al.', 'Karvonen MJ', 'Kenya', 'Kenya National Guidelines for cardiovascular disease management (2018)', 'Kenya national guidelines for cardiovascular diseases management', 'Keys A', 'Keys MH', 'Klein et al. (2015)', 'Klotho', 'Klotho gene', 'Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL', 'Knowledge, attitudes and practices related to stroke in Ghana and Nigeria: A SIREN call to action', 'Kotseva K.', 'Kralj V', 'Kwara state, Nigeria', 'LDL cholesterol', 'LDL target value', 'LDL-C', 'LDL-C ≥ 130 mg/dL', 'LMIC', 'LV contractility', 'Lai et al (2018)', 'Lancet 2002; 360: 7-22.', 'Lancet HIV', 'Lancet Infect Dis 2015', 'Lancet Neurol 2016', 'Lang et al (2010)', 'Large', 'Large meta-analysis', 'Laura A Benjamin, PhD', 'Law MR', 'Legume consumption', 'Legumes', 'Level of fat and blood sugar, BP, body weight', 'Leveraging rapid community-based HIV testing', 'Lifestyle optimisation', 'Lipid Analysis', 'Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH, Willett WC', 'Location', 'Low HDL-C', 'Low female participation', 'Low level of education', 'Low risk', 'Low socioeconomic status', 'Lundgren J', 'Lyon Diet Heart Study', 'M, Wylie-Rosett J', 'Major depressive disorder', 'Malawi', 'Malawi HIV Testing Services Guidelines (2016)', 'Malawi Med J', 'Malawian adults', 'Malawians in HIV care', \"Managing Measurable Variable Cardiovascular Disease' Risk Factors\", 'Manson JE', 'Manuscript', 'Marin C', 'Markers of cardiovascular risk', 'Markers of inflammation, coagulation, and renal function', 'Martín-Arnau AM', 'Martínez JA', 'Martínez-González MA', 'Massachusetts General Hospital', 'Matthew J Feinstein, MD', 'McAlister F, Marzona I, Dagenais GR, Teo KK, Yusuf S, Jung H, Turnbull F, Neal B, Chalmers J, MacMahon S, Lowering BP, Gerstein H, Marre M, Fox K, Simoons M, Nissen S, Heerspink HL, Brenner B, De Zeeuw D, Pfeffer M, Kober L, Diener HC, Sacco R, Renin Angiotension System Modulator Meta-Analysis Investigators', 'Mean age (SD)', 'Measure of effect', 'Measure of effect was the incidence rate per 100 000 person-years', 'Mechanisms of HIV-associated cardiovascular disease', 'Median age', 'Medicare Supplemental and Coordination of Benefits databases', 'Mediterranean Diet', 'Mediterranean diet', 'Mediterranean diet supplemented with olive oil', 'Mediterranean diet type', 'Mediterranean-style diet', 'Mellen P, Walsh TF, Herrington DM', 'Men', 'Menisk GBM', 'Menotti A', 'Mente A, de Koning L, Shannon HS, Anand SS', 'Merz CN', 'Meta-analysis of individual patient data', 'Metiterranean diet arms of the trial', 'Million Hearts', 'Ministry of Health', 'Mixed-gender trials', 'Mnatzaganian G', 'Moderate CVD risk', 'Moderate risk', 'Moderate to high risk', 'Morbidity and Mortality Weekly Report MMWR September 13, 2011, Vol. 60', 'More Widmer et al.', 'Morris JK', 'Myocardial infarction', 'N Engl J Med', 'N Engl J Med 2006; 355: 2283–96', 'NCEP', 'NCEP guidelines', 'NEJM', 'NHANES', 'NHANES data', 'NIH Public Access', 'NIH-PA', 'NIH-PA Author Manuscript', 'NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript', 'NO bioavailability and antioxidant', 'NONTRADITIONAL RISK FACTORS', 'Nahumi N', 'National Health and Nutrition Examination Survey', 'Neil HA', 'Neurology 2016; 86: 324–33.', 'Niebauer J', 'Nigeria', 'Nitrogen-fixing bacteria on their roots', 'No HIV-specific recommendation', 'No studies', 'Non-HIV specific mechanisms', 'Non-Modifiable', 'Non-traditional cardiovascular disease risk factors', 'Noncommunicable disease clinic', 'Normal BP', 'North and Sinclair Page 8', 'Northwestern University Feinberg School of Medicine, Chicago, IL, USA', 'Number of AMI events', 'Number of HIV cases', 'Number of participants', 'Number of people', 'Nurse-driven clinics', \"Nurses' Health Study\", 'Nut consumption', 'Nutr Metab Cardiovasc Dis', 'Nutr Metab Cardiovasc Dis. 2008; 18(4):283–90', 'Nutrition Committee', 'Nyyssonen K', 'OD', 'Observational and ecological studies', 'Observational studies', 'Odds ratio', 'Odds ratio 3·2 (1·1–8·9)', 'Olive Oil', 'Omega-3 Polyunsaturated Fats', 'Omega-3 fatty acids and coronary heart disease risk', 'Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis. 2008; 197:12–24. [PubMed: 18160071]', 'Online Referencing', 'Optimal BP', 'Organ Damage', 'Outcome Measure', 'Outcome Measure of effect', 'Outcomes of people with HIV', 'Overwhelming benefit', 'PAD', 'PI3K/AKT inhibitors LY294002 and wortmannin', 'PI3K/AKT signaling pathway', 'PLoS Med', 'PLoS Med 2010', 'PLoS One 2014; 9: e89444', 'PLoS One 2017; 12: e0172897', 'PLoS One 2018', 'PMC', 'PMC 2012 October 13', 'PMC 2022 August 03', 'PREDIMED-Reus nutrition intervention randomized trial', 'Page 10', 'Page 13', 'Page 18', 'Page 19', 'Page 2', 'Page 26', 'Page 27', 'Page 28', 'Page 32', 'Page 7', 'Page 8 Lancet HIV', 'Pancreatitis', 'Participants', 'Patel P', 'Patient group', 'Pearce D, Ani C, Espinosa-Silva Y , et al.', 'People ageing with HIV', 'People with HIV', 'Perez-Martinez P', 'Peripheral Artery Disease (PAD)', 'Peripheral artery', 'Peripheral artery disease', 'Philadelphia', 'Physicians’ Health Study', 'Physician’s Health Study', 'Pit-1', 'Pituitary Transcription Factor 1', 'Polypharmacy', 'Poor eating habits', 'Population', 'Population and geographic location', 'Population-based Data', 'Population-based HIV-negative groups', 'Postulated reasons', 'Poulsen HE', 'Prediction model of global risk', 'Predictors and outcomes', 'Pregnancies', 'Pregnancy', 'Prevalence', 'Prevalence and risk factors of peripheral artery disease', 'Prevalence of raised blood cholesterol', 'Prevention of cardiovascular disease in women', 'Preventive measures depend strongly upon length of time', 'Primary cardiovascular disease', 'Primary cardiovascular disease prevention', 'Primary endpoint', 'Prolonged QT intervals', 'Proper energy intake with regular physical activity', 'Proposed Mechanisms', 'Prospective Study', 'Protease inhibitor exposure', 'Protective effect', 'PubMed', 'PubMed: 11477461', 'PubMed: 15110203', 'PubMed: 15364995', 'PubMed: 16785338', 'PubMed: 16818923', 'PubMed: 17449231', 'PubMed: 20307353', 'PubMed: 21245490', 'PubMed: 22942209', 'PubMed: 24621875', 'PubMed: 26971657', 'PubMed: 28384660', 'PubMed: 29535090', 'PubMed: 29952795', 'PubMed: 29967196', 'PubMed: 30444884', 'PubMed: 30571387', 'PubMed: 30819366', 'PubMed: 7598116', 'PubMed: 7885425', 'PubMed: 9184593', 'PubMed: 9989963', 'Publication', 'Publication Year', 'Publication details', 'Publication reference', 'Publication source', 'Publication: 15132735] ', 'Publication: 8339414] ', 'Qureshi et al.', 'RCT', 'RCT data', 'RCTs', 'RCTs studies', 'RF', 'ROS in CVD', 'Race', 'Raised blood pressure', 'Ramirez R', 'Reasons for not using the SCORE table in daily practice', 'Recent acute coronary syndrome', 'Recent meta-analyses of observational studies', 'Recently reported', 'Reduces risk of other chronic diseases', 'Regularly consume fish', 'Relative effect estimate', 'Relative risk', 'Removal of senescence cells alone', 'Reprints', 'Research paper', 'Researchers', 'Revascularization', 'Review Article', 'Reynolds HR, Srichai MB, Iqbal SN, et al.', 'Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC.', 'Risk Factor', 'Risk for Cardiometabolic Disease', 'Risk of coronary heart disease', 'Rose CE', 'Rural African population', 'Rural sub-Saharan Africa', 'Russia', 'Régie de l’Assurance maladie du Québec, Canada', 'S32-42', 'SBP', 'SCORE >1% and less than 5%', 'SCORE >10%', 'SCORE >5% and less than 10%', 'SCORE chart:', 'SCORE table to estimate CVD risk', 'Sabin C', 'Saeed A', 'Salas-Salvadó J, Bulló M, Babio N, Martínez-González MÁ, Ibarrola-Jurado N, Basora J, Estruch R, Covas MI, Corella D, Arós F, Ruiz-Gutiérrez V, Ros E, PREDIMED Study Investigators', 'San Francisco, California, USA', 'Sav A', 'See Online', 'Send Orders for Reprints', 'Serum Markers', 'Servings per week', 'Seven Countries Study', 'Seven-Countries Study', 'Shah and others', 'Should be consumed in moderation', 'Sico et al (2015)', 'Single-sex studies', 'Smit M, Brinkman K, Geerlings S, et al.', 'So-Armah et al.', 'So-Armah et al. Author Manuscript', 'So-Armah et al. Page 15', 'So-Armah et al. Page 3', 'Social isolation and low social support', 'Some evidence', 'Somerset S', 'Sonja Frančula-Zaninović1,* and Iskra A. Nola2', 'Source:', 'South Africa', 'South Africa: stroke units out of the blue', 'South America', 'Stage 1', 'Stage 2', 'Stampfer MJ', 'Standardised Incidence rate', 'Statement 62', 'Statins', 'Statistics Committee', 'Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I. Factors affecting low-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). Am J Cardiol 2002; 90: 731-6.', 'Strengths and weaknesses', 'Stroke', 'Stroke Hazard ratio 2·3', 'Stroke Statistics Subcommittee', 'Structural measures', 'Studies', 'Studies on HIV and Peripheral artery disease', 'Study', 'Study location', 'Study title', 'Sub-Saharan Africa', 'Subclinical marker', 'Subjective assessment', 'Sudden cardiac death', 'Survival', 'Systematic Review', 'Systemic Coronary Risk Estimation (SCORE) tables', 'Systemic autoimmune disorders', 'Systolic BP (mmHg)', 'Systolic Blood Pressure', 'Systolic blood pressure', 'T cells', 'TC ≥ 200 mg/dL', 'TC ≥ 240 mg/dL', 'Table 1:', 'Table 3', 'Taiwan Centers for Disease Control', 'Tanzania', 'Task Force for the management of arterial hypertension', 'Textbook of cardiovascular medicine', 'Thailand', 'The Task Force for the Management of Dyslipidaemias', 'The association', 'Time trends of myocardial infarction incidence among people with HIV in high-income countries', 'Title of the review article', 'Tobacco', 'Tobacco Hypertension Diabetes Dyslipidaemia Drug interactions', 'Total LDL cholesterol', 'Trends in the incidence of coronary heart disease', 'Triant V A, Perez J, Regan S, et al.', 'Triant et al (2009)', 'Triglyceride-rich lipoprotein', 'Truven Health MarketScan', 'Tseng et al (2012)', 'Tseng et al (CROI 2019, unpublished)', 'Type 2 Diabetes', 'UCL Queen Square Institute of Neurology, University College London, London, UK', 'USA', 'USA79', 'USA95 and sub-Saharan Africa96', 'USPTF', 'Uganda', 'Underpowered studies', 'United States', 'Unsaturated Fats', 'Uriel N', 'Use vegetable', 'Van Horn L', 'Vasc Health Risk', 'Velich T', 'Very high risk', 'Veterans Aging Cohort Study', 'Virgin Olive Oil Study (VOLOS)', 'Visioli F', 'Vol. 14, No. 3', 'W.B. Saunders Company', 'WHO International Classification of Diseases', 'WHO Map Gallery', 'WHO regions', 'WHOLEheart', 'Waist size', 'Wald NJ', 'Warning symptoms', 'Weber R', 'West of Scotland Coronary Prevention Study', 'West of Scotland Coronary Prevention Study (WOSCOPS)', 'Western Europe', 'White JR', 'Whole grain intake and cardiovascular disease: a meta-analysis', 'Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health', 'Wide variety of sources and types difficult to study', 'Widmer et al.', 'Women', 'Women ≥ 20 years', 'World Health Organization', 'World Population Maps', 'World maps', 'Worm SW', 'Young Stroke Study', 'Yubero-Serrano EM', 'Yusuf S, Hawken S, Ounpun S, et al.', 'Yzebe D, Lievre M', '[48] Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I. Factors affecting low-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). Am J Cardiol 2002; 90: 731-6.', '[49] Gotto AM Jr, Bocuzzi SJ, Cook JR.', '[PubMed: 20929998]', 'a healthy diet', 'a modelling study', 'a randomised placebocontrolled trial', 'a scientific statement from the American Heart Association', 'a shortened lifespan', 'a weaker prognosis of CVD', 'abnormal ankle-brachial index (ABI)', 'absence of concrete risk factor assessment', 'absolute and relative risks', 'absolute rates of acute myocardial infarction', 'abundance of', 'abundance of observational data', 'access to antiretroviral therapy', 'access to care for people with HIV', 'access to essential medicines', 'access to life-preserving combination antiretroviral therapy (ART)', 'according to', 'according to ESC recommendations', 'achieve the target BP', 'acute CV events', 'acute coronary syndrome', 'acute myocardial infarction', 'additional risk in women', 'adequate psychosocial support', 'adherence', 'administration of olive oil', 'adult Malawians in HIV care', 'adults', 'adverse events', 'age', 'age group', 'age groups', 'age-related results', 'aging HIV-infected population', 'aging cardiovascular system', 'aging genes', 'aimed at improving cardiovascular health', 'albuminuria', 'alcohol consumption', 'algorithm', 'algorithm according to ESC', 'altered cholesterol metabolism', 'altered coagulation', 'anatomical features', 'and BP', 'and Northern California health plans', 'anti-HIV drugs', 'anti-hypertensives', 'anti-inflammatory and vaso-protective benefit', 'antihypertensive drugs', 'antioxidant properties', 'antiretroviral therapy', 'antiretroviral therapy and survival', 'antiretroviral treatment', 'anxiety', 'aortic coronary bypass', 'apolipo-proteins', 'appreciable amounts', 'approaches to cardiovascular disease risk reduction', 'arterial hypertension', 'ascertain the effect of HIV control and risk factor control', 'ascribing the benefit solely to nuts', 'aspirin', 'aspirin for primary prevention of cardiovascular disease', 'associated vasculopathy', 'association of HIV status and clinical cardiovascular disease', 'asthma', 'asymptomatic for a long time', 'asymptomatic patients', 'atherogenesis', 'atherosclerosis', 'atherosclerosis or cardiomyopathies', 'atherosclerotic', 'atherosclerotic cardiovascular disease risk calculator', 'atherosclerotic disease', 'author', 'author manuscript', 'authors', 'autoimmune diseases', 'available at:', 'balance', 'baseline endothelial function', 'beneficial effect on health', 'beneficial effects of fish', 'beneficial for both primary and secondary prevention of cardiovascular disease', 'benefit of soy', 'benefit of whole grains on cardiovascular disease', 'benefits', 'benefits of fish', 'best culinary interventions', 'best-studied diet', 'between 70-189 mg/dL', 'biological sex', 'biomarkers', 'biomarkers of chronic inflammation', 'black Africans with HIV infection', 'black women', 'blood pressure', 'blood pressure control rates', 'blood pressure elevation', 'blood pressure thresholds', 'blood–brain barrier', 'body activity', 'body weight regulation', 'brian_north@hms.harvard.edu', 'cancer', 'cardiac and pulmonary health', 'cardiac arrhythmias', 'cardiac death', 'cardiac output', 'cardio-protection', 'cardio-protective effects of olive oil', 'cardio-vascular resource utilization', 'cardio-vascular resource utilization and', 'cardiologist', 'cardiometabolic stressor', 'cardiomyocytes undergo necrosis', 'cardiomyopathy', 'cardiovas-cular', 'cardiovas-cular patients', 'cardiovascular benefits', 'cardiovascular disease', 'cardiovascular disease (CVD)', 'cardiovascular disease benefit', 'cardiovascular disease benefits', 'cardiovascular disease burden', 'cardiovascular disease in HIV-positive persons', 'cardiovascular disease morbidity', 'cardiovascular disease morbidity and mortality benefit', 'cardiovascular disease morbidity and mortality reduction', 'cardiovascular disease morbidity or mortality', 'cardiovascular disease mortality', 'cardiovascular disease prevention', 'cardiovascular disease prevention benefits', 'cardiovascular disease risk', 'cardiovascular disease risk factor', 'cardiovascular disease risk factor profile', 'cardiovascular disease risk factors', 'cardiovascular disease risk reduction', 'cardiovascular disease surrogate and morbidity benefit', 'cardiovascular diseases', 'cardiovascular events', 'cardiovascular function', 'cardiovascular function differences', 'cardiovascular morbidity/mortality benefits', 'cardiovascular patients', 'cardiovascular risk', 'cardiovascular risk factors', 'cardiovascular risk markers', 'cardiovascular risk profile', 'case-control study', 'cases of heart failure', 'cases where doubts remain about the need for introducing therapy with preventative measures or there are various contraindications and/or complications.', 'catabolic state', 'cause of stroke', 'centenarians', 'cerebrospinal fluid HIV escape syndrome', 'certain aspects of the diet which are particularly beneficial for', 'change in overall serum lipid profiles', 'check fasting plasma glucose', 'chest pain', 'childhood', 'cholesterol', 'cholesterol absorption inhibitors', 'chronic', 'chronic comorbidities', 'chronic diseases', 'chronic inflammation', 'chronic kidney disease', 'chronic, cumulative comorbidities', 'cigarette smoking', 'circulating hormone-like factor', 'ciz407', 'clinic-level screening programmes', 'clinical cardiovascular disease', 'clinical care of an ageing population infected with HIV', 'clinical indications', 'clinical symptoms of depression', 'clinical symptoms of depression, anxiety', 'clinical trials', 'clinically appropriate cardiac evaluation', 'cohort risk equation', 'colesevelam', 'collaborator', 'collection of healthy nutrients', 'combination', 'combination of drugs', 'community, schools and workplaces', 'concept', 'conflicts', 'consideration in women with breast cancer', 'considered seeds of plants that contain roots', 'consistent approach', 'constituents of the Mediterranean diet', 'consultant and inventor', 'consumed in isolation', 'consumer-friendly', 'consumption', 'contraindication to heart', 'contribute to', 'contribution', 'contribution of the constituents', 'copious, yet congruent, observational and RCT data', 'coronary arteries or heart surgery', 'coronary artery disease (CAD)', 'coronary dis-ease', 'coronary heart disease', 'coronary heart disease and stroke prevention', 'coronary heart disease mortality', 'coronary heart disease prevention', 'coronary heart disease risk', 'coronary heart disease risk factor burden', 'coronary heart disease risk factors', 'coronary heart disease risk screening', 'coronary heart disease-related clinical endpoints', 'coronary illness', 'coronary intervention', 'correction', 'cost of annual health care for CVD', 'counseling', 'countries', 'critical component', 'current primary care', 'current recommendation', 'cytomegalovirus', 'data', 'data from China', 'data from Japan', 'data supporting aspirin use', 'data-collection on adverse effects of anti-HIV drugs', 'david_sinclair@hms.harvard.edu', 'de Irala J', 'de la Fuente C', 'de-Graft Aikins A', 'deaths per year', 'decision-making', 'decline in function with age', 'decrease in intake of alcoholic beverages', 'decreased physical activity', 'decreasing risks of AIDS-related deaths', 'deep clinical phenotyping', 'defense response', 'deficient vascular and cardiac growth', 'defined monitoring parameters', 'denmark-country-of-the-month-full-report.pdf', 'depletion of CD4+', 'depression', 'depression and anxiety disorders', 'determinant', 'developed by GSK', 'developed world', 'developing CVD', 'development in the aging', 'development of complications', 'device and mechanical therapies for heart failure', 'diabetes', 'diabetes mellitus', 'diabetes mellitus type 2 without other risk factors or target organ damage', 'diagnostic criteria', 'diastolic and systolic dysfunction', 'diastolic compliance', 'diastolic for 10 mmHg', 'diet', 'dietary caloric distribution', 'dietary factors', 'dietary flavonol intake', 'dietary measures, physical activity, smoking', 'diets', 'different defibrillator thresholds', 'difficult treatment', 'direct cardiovascular disease benefit', 'dis-ease', 'discordant CSF/plasma HIV-1 RNA', 'discuss genetic pathways', 'discussed in this Review (figure 3)', 'disease', 'disease severity', 'disparities', 'distribution', 'disturbed lipid metabolism', 'diuretics', 'doi', 'dolutegravir-based regimen', 'domain of', 'dose titration', 'drug discoveries', 'drug interactions', 'drugs (corticosteroids, estrogens, tamoxifen, beta blockers, thiazides)', 'dyslipidaemia', 'dyslipidemia', 'e015385', 'e1000224', 'e279–e293. doi:10.1016/S2352-3018(20)30036-9.', 'each risky CVD factor in diabetes', 'earlier meta-analysis', 'early observational data', 'eating habits', 'echocardiographic and Doppler artery estimation', 'effect estimate', 'effect on hard cardiovascular disease endpoints', 'effective prevention and treatment of heart failure in people with HIV', 'effective therapies', 'effort to reduce coronary heart disease risk', 'ejection fraction', 'elevated LDL cholesterol', 'elevated blood pressure', 'elevated blood pressure prevalence', 'elevated calcium score', 'elevated cholesterol cases', 'elevated high-sensitivity C-reactive protein (hs-CRP)', 'elevated hs-CRP', 'elevated lipoprotein(a)', 'embryonic lethality', 'emphasis on stroke', 'endothelial damage', 'endothelial function', 'entire community', 'epidemiological data', 'epidemiology', 'era of personalized medicine', 'established CVD', 'establishing sudden cardiac death risk', 'estimate by HIV', 'estimates', 'estrogen', 'estrogen for premenopausal women', 'estrogen receptors expressed both in vascular endothelial and smooth muscle cells', 'et al.', 'ethanol-extracted soy protein', 'etiology of stroke', 'evaluate the risk of CVD', 'everyday medical work', 'evidence', 'evidence of subclinical atherosclerosis', 'evidence-informed strategies', 'examining', 'exceptions unique to women', 'excess in HIV', 'excess weight gain', 'excessive alcohol', 'experience depression at approximately twice the rate of men', 'experience disparities', 'expert health-care and patient', 'expert opinion', 'experts', 'exploring', 'exposure', 'exposure to risk factors', 'expression of', 'external factors', 'extra virgin olive oils', 'extracranial carotid and vertebral', 'ezetimibe', 'factor', 'failure', 'failureHazard ratio', 'familial hypercholesterolemia', 'family history of cardiovascular disease', 'family history of premature ASCVD', 'farmers of Crete', 'fasting lipid profile', 'fasting plasma glucose', 'fat diet', 'fatal CVD outcomes', 'fatal cardiovascular events', 'fatal ischemic heart disease', 'favorable', 'female population', 'female sex', 'few data', 'fewer monocytes, inflammatory markers', 'fiber', 'fibrate', 'first ESC pre-vention guidelines', 'fish', 'fish and nuts', 'fish intake', 'fish intake versus fish oil supplementation', 'fish oil', 'fish, monounsaturated fats from olive oil, fruits, vegetables, whole grains, legumes/nuts, moderate alcohol consumption', 'fluctuating trends in weight gain', 'follow up', 'food industry', 'food products', 'for HIV-related heart failure prevention and treatment', 'for appendix', 'for high blood pressure in adults', 'for primary prevention in both women and men aged 50 to 59 years who have a 10% or greater 10-year CVD risk without an increased risk of bleeding', 'fresh fruit daily', 'fried', 'from 1995 to 2014', 'fruit and vegetable intake', 'fruit and vegetables', 'fruit daily increase', 'fruits and vegetables', 'future challenges', 'future stress', 'gastrointestinal bleeding', 'gender', 'gender-based differences', 'gene alterations', 'gene that is mutated', 'general CVD risk factors', 'general Spanish male population', 'general population', 'general recommendations of a healthy diet', 'genetic and pharmacological interventions', 'genetic heritage', 'genetic predisposition', 'geographical location', 'gestational hypertension disorders', 'global context of HIV', 'global risk prediction model', 'glucose', 'glucose metabolism', 'goal', 'goal body mass index (BMI)', 'good body weight control', 'governmental organizations', 'greater cardiovascular disease benefit', 'greater inclusion of women and sex-stratified analyses', 'greater risk of CVD', 'group of people with already manifest atherosclerotic vascular disease', 'grouped data', 'guidelines', 'guidelines for CV prevention', 'guidelines for women', 'hard cardiovascular disease endpoints', 'harmful effects', 'has risk factors for bleeding', 'have', 'have been less convincing regarding cardiovascular', 'health', 'health care professionals', 'health centres', 'health education', 'health policies', 'healthy diet', 'healthy eating', 'healthy environment', 'healthy habits', 'healthy lifestyle habits', 'healthy lifestyle recommendation', 'healthy living habits', 'healthy meals', 'healthy middle-aged persons', 'healthy nutrients', 'heart and circulatory system disorders', 'heart disease', 'heart disease risk factors', 'heart disease risks', 'heart failure', 'heart failure in HIV', 'heart failure presentations and triggers', 'heart failure risk factors', 'heart failure with preserved ejection fraction', 'heart failure with reduced ejection fraction and preserved ejection fraction', 'heart rate modulation', 'heart-healthy diet', 'hemoglobin A1c', 'hemostatic risk factors for coronary heart disease', 'hereditary dyslipidemia', 'heterogeneity', 'high CVD risk', 'high cardiovascular risk', 'high cholesterol diets', 'high concentrations', 'high doses of statin', 'high relative risk', 'high risk for the disease', 'high total CV risk', 'high triglycerides', 'high-income countries', 'high-income settings', 'high-intensity statin therapy', 'high-risk individuals', 'higher', 'higher amounts of fish intake', 'higher incidence of smoking', 'higher increase in CVD', 'higher odds', 'higher prevalence of elevated blood pressure', 'higher prevalence of elevated cholesterol', 'higher risk of myocardial infarction (MI)', 'higher risk of stroke', 'higher smoking rates', 'hormonal differences', 'http://gamapserver.who.int/mapLibrary/app/searchResults.aspx', 'http://www.escardio.org/', 'http://www.revespcardiol.org/eu/global-preventive-policies-strategies-at/articulo/13125894.', 'https://academic.oup.com/eurheartj/article/37/29/2315/1748952/2016-European-Guidelines-on-cardiovascular-disease', 'human immunodeficiency virus infection', 'human immunodeficiency virus-infected individuals', 'human immunodeficiency virus/acquired immunodeficiency syndrome epidemic', 'human immunodeficiency virus–infected adults', 'hypercholesterolaemia', 'hypercholesterolemia', 'hypertension', 'hypertension and stroke', 'hypertension management', 'hypertensive heart disease', 'hypertriglyceridaemia', 'hypertriglyceridemia', 'hypothyroidism', 'hypoxia-induced angiogenesis in tumors', 'hypoxia-inducible factor-1 α stabilization', 'identification of targets', 'if target values of LDL C not reached', 'illness', 'immune restoration', 'immune status', 'immunological and inflammatory contributors', 'impaired cardiac looping', 'impaired cardiomyocyte proliferation', 'implementation science', 'improve cardiac outcomes', 'improved all cause and cardiovascular disease mortality', 'improvements', 'improvements in surrogate markers for cardiovascular disease', 'improves the arterial wall response to injury', 'in both women and men aged 50 to 59 years who have a 10% or greater 10-year CVD risk without an increased risk of bleeding', 'in-hospital mortality from acute myocardial infarction', 'inadequate physical activity', 'incidence', 'incidence of CVD in individual countries', 'incidence of ischemic stroke', 'incidence of sudden cardiac death in the setting of ischaemic heart disease', 'incident acute myocardial infarction', 'incident clinical events', 'incident diabetes', 'income status', 'increase in BP', 'increase in oxidative stress', 'increase in oxidative stress due to', 'increase in reactive oxygen species (ROS) production', 'increase in reactive oxygen species (ROS) production with age', 'increase in relative risk', 'increased awareness', 'increased body weight (obesity)', 'increased consumption of whole-grain foods', 'increased fish intake', 'increased intestinal permeability', 'increased lifespan', 'increased nut consumption', 'increased peripheral artery disease', 'increased physical activity', 'increased relative risk', 'increased risk', 'increased risk of cardiovascular disease', 'increased risk of premature deaths', 'increased risk of sudden cardiac death', 'increased whole grain intake', 'increased whole-grain intake', 'increases the incidence of CVD and exacerbates the prognosis of the disease', 'increases the risk of CVD', 'increasing phenolic content', 'independent', 'individual', 'individuals', 'individuals in sub-Saharan Africa (SSA)', 'individuals on CR diets', 'individuals on antiretroviral therapy', 'indoor air pollution', 'ined.fr/en/everything_about_population/graphs-maps/world-maps-interactiv', 'infarction', 'infectious myocarditis', 'inflammatory and immune disorders', 'inflammatory and oxidants mediators', 'inflammatory diseases', 'inflammatory effect', 'inflammatory markers', 'inflammatory process', 'inflammatory response', 'inflammatory vasculopathy', 'insulin sensitivity', 'intact soy protein', 'intake', 'integrated HIV and cardiovascular disease care models', 'integrated care approach', 'integrated services', 'interact with', 'interventions', 'interview', 'interviews or questionnaires', 'intestinal barrier dysfunction', 'intracranial HIV-associated vasculopathy', 'introductory review', 'invasive procedures', 'inverse correlation between blood pressure and monounsaturated fats intake', 'ionic exchangers', 'ischaemic post-myocardial infarction', 'ischaemic stroke', 'ischemic heart dis-ease', 'ischemic stroke', 'isocaloric consumption of fish', 'isoflavones', 'isolated right heart failure', 'journal publication', 'key', 'kindergarten', 'lack of recognition', 'lack of social support', 'large meta-analysis', 'large studies', 'last 5 years', 'leading cause', 'leading cause of death', 'leading causes of maternal and fetal morbidity and mortality', 'left ventricular size', 'legislation to reduce availability of trans-fatty acids', 'legume and soy intake', 'legume intake', 'levels of thromboxane B2', 'life habits and pharmacotherapy', 'life habits in BP reduction', 'life-style habits', 'lifestyle choices', 'lifestyle interventions vs. control', 'lifestyle modifications', 'lifestyle optimisation strategies', 'light exercise', 'limited dairy products', 'limiting marketing, taxing unhealthy food, reducing price of healthy food, making them better labelled, consumer-friendly', 'linear decrease in markers of oxidative stress', 'lipid levels', 'lipid profile', 'lipid profiles', 'lipids', 'little direct evidence', 'logarithmic conversions and standard errors', 'long-term effect', 'longevity benefit', 'low CD4 T-cell counts', 'low HDL cholesterol', 'low LDL cholesterol', 'low amounts', 'low financial income', 'low high density lipoproteins (HDL) cholesterol', 'low income country', 'low level of business status', 'low social support', 'low socioeconomic status', 'low-dose aspirin', 'low-fat diets enriched with nuts or olive oil (12)', 'low-glycemic', 'low-income and high-income settings', 'low-income and middle-income countries', 'low-income countries', 'low-income countries in sub-Saharan Africa', 'low-moderate risk patients', 'low-resource settings', 'lower LDL-C', 'lower body mass index', 'lower prevalence of elevated', 'lower prevalence of elevated cholesterol', 'lower risk', 'lower smoking rates', 'lower tobacco smoking rates', 'lowering drugs', 'lowest cardiovascular mortality rate', 'mainly secondary prevention', 'malignant arrhythmias', 'man-agement in clinical practice', 'management', 'management of psychosocial factors', 'manuscripts', 'marine omega-3', 'marker for fundamental damaged DNA pathways', 'materials and data access', 'may include menopause, hypertensive disease of pregnancy, and depression', 'measures in childhood', 'measures such as physical activity', 'measures such as smoking cessation', 'mechanisms', 'mechanistic studies', 'mediators', 'medical evaluation', 'men', 'men and women', 'mercury toxicity', 'meta-analyses', 'meta-analysis', 'meta-analysis of four observational studies', 'metabolic syndrome (12), diabetes (11)', 'microbial translocation', 'microvasculature', 'middle income country', 'middle-income countries', 'mildly dyslipidemic patients', 'minor polar compounds', 'misunderstanding', 'mitochondrial-targeted catalase mice', 'mixed dyslipidemia', 'moderate amounts of fish, poultry, and wine', 'moderate fish intake', 'moderate to severe chronic kidney dis-ease', 'moderate to severe chronic kidney dis-ease, SCORE >10%', 'monitoring and assistance', 'monitoring parameters', 'monitoring them', 'mono and polyunsaturated fats', 'monocyte activation', 'monounsaturated fats', 'monounsaturated fatty acid intake', 'more antihypertensive drugs', 'more benign cardiovascular disease side effect profiles', 'more difficult to accept medical advice and treatment', 'more pronounced in women', 'mortality', 'mortality from ischaemic heart disease', 'mortality in patients', 'mortality rate', 'most important factors in cardiovascular disease management', 'move into an era', 'multidisciplinary team of experts', 'multidrug regimens', 'multifac-torial diseases', 'multimodal behavioural interventions', 'multiple factors', 'multiple risk factors', 'muscle mass', 'myocardial infarction', 'myocardial infarction among people with HIV', 'myocardial infarction risk', 'myocardial infarction, stroke, and heart failure', 'myocardium', 'myocardium thickness', 'n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored', 'n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond). 2004; 107(1):1–11. [PubMed: 15132735]', 'national, cultural and socioeconomic aspects', 'natural defense pathways', 'neighboring cardiomyocytes', 'new ESC Guidelines on CVD prevention', 'next generation', 'niacin', 'nico-tinic acid', 'nicotinic acid', 'no evidence', 'no specific component', 'non toleration', 'non-communicable disease services', 'non-depressed women', 'non-governmental organizations', 'non-insulin-dependent diabetes mellitus (NIDDM)', 'non-traditional cardiovascular disease risk factors', 'noncommunicable cardiovascular and pulmonary diseases', 'normal development and function', 'normotensive patients', 'not cardiovascular disease morbidity or mortality and their complications', 'not convincing', 'nuts', 'obese people', 'obesity', 'observational studies', 'older age group', 'older population', 'olive oil', 'olive oil consumption', 'olive oil supplementation', \"olive oil's phenolic compounds\", 'omega 3 fats', 'omega 3 fatty acid', 'omega 3 fatty acids', 'omega-3 fatty acid supplementation', 'omega-3 fatty acids', 'on cardiovascular disease outcomes', 'one BP lowering medication', 'opportunistic infection', 'optimal management', 'optimal results', 'other diseases', 'other factors', 'other risk factors', 'other viral infections', 'outcomes comparable', 'over 200,000 patients', 'over 90,000 participants', 'overall effect of irisin', 'overall enhancement in the rate of cardiomyocyte death with age', 'overall morbidity and mortality', 'overexpression of Klotho', 'overload–induced', 'overt AIDS cardiomyopathy', 'overweight', 'oxidative stress', 'p66shc knockouts', 'pancreatitis', 'passive smoking', 'patents licensed to GSK', 'pathophysiology of CVD in women', 'patient', 'patient education', 'patient inadequacy', 'patient tolerates', \"patient's\", \"patient's condition\", \"patient's health\", 'patients', 'patients living with heart failure and human immunodeficiency virus', 'patients on the Mediterranean diet', 'patients received olive oil', 'patients with', 'patients with advanced peripheral artery disease and poor', 'patients with high', 'patients with high and very high risk', 'patients with moderate hypertension ( 94)', 'patients with mutants in Pit-1', 'patients with type 2 diabetes mellitus', 'patients without overt atherosclerosis', 'people living with HIV', 'people who live isolated from society', 'people with HIV', 'people with HIV at high risk for cardiovascular disease', 'people with HIV who had', 'people without HIV', 'peripheral arterial disease', 'peripheral artery disease', 'peripheral artery disease and sudden cardiac death', 'persistent blood pressure 140/90 mmHg', 'person', 'pharmacological treatment', 'phenolic content', 'phenols', 'phosphate reabsorption and metabolism', 'physical activities', 'physical activity', 'physical inactivity', 'physical inactivity of young people', 'physician-patient discussion', 'physicians', 'physiology consistent with protection from CVD', 'phytochemicals', 'pituitary transcription factor 1', 'plant foods', 'plaque instability', 'polypharmacy', 'polyphenols in olive oil', 'poor eating habits', 'poor living environment', 'poor psychosocial factors', 'population approach', 'population at high cardiovascular risk', 'population effect metrics', 'population health approaches', 'populations included in published HIV-related cardiovascular disease research', 'portions', 'potential benefit', 'potential of olive oil', 'preeclampsia', 'pregnancy', 'premature aging phenotypes', 'premature mortality', 'premature mortality across', 'presence of phenolic compounds', 'preserved ejection fraction', 'prevalence', 'prevalence estimates', 'prevalence of elevated', 'preventative CVD measures', 'preventative cardiovascular medicine', 'preventing cardiovascular disease', 'preventing cardiovascular disease development', 'prevention', 'prevention and', 'prevention and management of CVD in women', 'prevention and treatment', 'primary benefit in trials', 'primary prevention', 'primary prevention RCT', 'primary prevention data', 'primary prevention of CVD', 'primary/secondary end points', 'principal source of fat', 'principal sources', 'pro-atherogenic genes', 'professionals', 'profile', 'progressively increases', 'proinflammatory and profibrotic environments', 'prolonged QT intervals', 'promotes re-endothelialization', 'protease', 'psychological interventions', 'psychological therapy', 'psychosocial factors', 'psychosocial risk factors', 'psychosocial support', 'psychotherapy and pharmacotherapy', 'public and individual health approaches', 'public education', 'public health importance', 'publication', 'publication bias', 'published in', 'racial and ethnic minorities', 'radiation', 'radiation exposure', 'radiotherapy regimens for breast cancer', 'randomised, controlled dietary intervention', 'randomized controlled trial', 'randomized controlled trials', 'randomized placebo-controlled trials', 'randomized trial', 'randomized, crossover controlled trial', 're-affirmed stance', 'recent meta-analyses including recent negative data', 'recent meta-analyses of trials examining medication adherence vs. placebo', 'recognizing individual risk factors, monitoring them, and assisting in changes', 'recommendations for dietary caloric distribution', 'recommendations for pharmacological treatment', 'recommended exercise time for women and men', 'recommended therapy', 'red meat', 'red meat consumption', 'reduce cardiovascular morbidity and mortality', 'reduce the burden, or prevent the development, of cardiovascular disease, breast cancer, depression, colorectal', 'reduced blood pressure', 'reduced body activity', 'reduced effect', 'reduced ejection fraction', 'reduced heart size', 'reduced inflammation, oxidation, and coagulation', 'reduced intake of salt in food', 'reducing ischaemic heart disease', 'reducing risk', 'reducing stroke burden', 'reductase inhibitor therapy', 'reduction', 'reduction of', 'reduction of already existing vascular lesions', 'reductions in other risk factors or cardiovascular disease mortality', 'reference', 'referral and risk factor management', 'regenerative capacity', 'regenerative capacity of endothelium', 'regular patient education', 'regular physical activity', 'relative', 'relative risk reduction', 'relative risks', 'release of cellular components', 'relevant risk reduction approaches for cardiovascular disease', 'remainder of the Mediterranean diet', 'renal tubular cells', 'repeat annually', 'repeated at 3 months after starting protease inhibitor', 'reprints@benthamscience.ae', 'research centers', 'response to β-adrenergic receptor activation', 'rheumatic heart disease', 'rise of factors', 'risk BP', 'risk evaluation and management', 'risk factor for', 'risk factors', 'risk factors for CVD', 'risk factors for coronary heart disease', 'risk factors such as metabolic syndrome', 'risk for CAD increases similarly in both men and women', 'risk markers', 'risk of CVD', 'risk of acute myocardial infarction', 'risk of coronary disease among men.', 'risk of fatal cardiovascular events', 'risk of high risk for the disease', 'risk of major cardiovascular disease events', 'risk of major cardiovascular events', 'risk of myocardial in-farction', 'risk progressively increases', 'risk reduction approaches for coronary heart disease', 'risk reduction globally', 'risk reduction of cardiovascular disease', 'risks and benefits', 'ritonavir and cobicistat', 'ritonavir-boosted protease inhibitor', 'robust data', 'robust progress', 'rodent studies', 'routine ASCVD risk assessment', 'salt reduction', 'saturated fats and carbohydrates', 'scaling up and scaling out', 'school', 'scientific community', 'scores', 'screening', 'screening programmes', 'screening programmes at the community-level', 'secondary and tertiary CVD prevention', 'secondary cardiovascular disease prevention benefit', 'secondary prevention of CVD', 'sedentary lifestyle', 'selection bias and recall bias', 'serum lipids', 'seven week treatment period', 'severe left ventricular systolic dysfunction', 'severe renal disease', 'severity', 'sex-based differences', 'short-term enhancement', 'shortened survival', 'significant positive family history', 'significantly high individual risk factors', 'signs and symptoms of peripheral artery disease', 'similar observational data', 'similar prevalence', 'simple carbohydrate-rich diets', 'simplicity', 'single out', 'single-pass transmembrane protein', 'sirtuin-related medicines', 'smokers', 'smoking', 'smoking cessation', 'smoking tobacco', 'source publication', 'soy', 'soy isoflavones', 'soy supplementation', 'soybean protein', 'specific food items', 'specific foods', 'stable So-Armah et al. Page 6 Lancet HIV', 'stable angina pectoris', 'stable disease', 'stable heart failure', 'stage of HIV infection', 'standardised incidence rate', 'statin', 'statin intolerance', 'statin safety data', 'statin therapy', 'statin use', 'statins', 'stress', 'stroke', 'stroke epidemiology', 'stroke patients with HIV', 'stroke preventive strategies', 'stroke treatments', 'stroke volume', 'strokes in people with HIV', 'studies', 'study', 'study in Cameroon', 'study location', 'study on mildly dyslipidemic patients', 'study title', 'styles', 'sub-Saharan Africa', 'sub-Saharan Africa (SSA)', 'subclinical cardiovascular disease', 'subjects', 'substance use disorders', 'success', 'successful management of measurable variable risk factors for cardiovascular disease development', 'such patients', 'sudden cardiac death', 'sudden cardiac death risk', 'sudden death', 'support', 'surrogate endpoints', 'surrogate markers', 'surrogate markers for cardiovascular disease', 'survival affected by released cellular components', 'sympathetic modulation of heart rate', 'systematic review', 'systematic review of RCTs', 'systemic inflammation', 'systemic lupus erythematosus', 'systolic for 20 mmHg', 'systolic function', 'tachycardia', 'target BP', 'target LDL C <1.8mmol/l and/or >50% LDL C', 'target LDL C <3.0mmol/l', 'target LDL K <2.5mmol/l', 'target not achieved', 'target values of LDL C', 'telomeric DNA loss effects in quiescent tissues', 'ten-year risk', 'testosterone', 'the task force for the diagnosis and treatment of peripheral arterial diseases', 'therapy combination', 'therapy era', 'those with negative affectivity, social inhibition - has a poorer prognosis of CVD', 'time period of the study', 'to prevent', 'tobacco', 'tobacco cessation', 'tobacco smoking rates', 'tobacco-product taxation', 'total CVD risk', 'total antioxidant capacity of plasma', 'traditional and non-traditional cardiovascular disease risk factors', 'traditional cardiovascular disease risk factors', 'traditional risk factors', 'traditional view', 'trans fat acid', 'transcriptional program', 'transforming growth factor beta(1)', 'translation platform', 'treatment approaches', 'treatment modalities', 'treatment of cardiovascular diseases', 'treatment of depression', 'treatment response', 'treatment thresholds', 'treatment, or lifestyle modification advice', 'trials', 'triglyceride-rich lipoproteins', 'triglycerides', 'triglycerides-rich lipoproteins', 'two medications of different class', 'type 1 and type 2 acute myocardial infarction events', 'type 2 DM', 'type 2 diabetes', 'type 2 diabetes mellitus (T2DM)', 'type D personality', 'unambiguous access to patients', 'uncontrolled HIV replication', 'undefined (non-vasculitic, non-atherosclerotic) vasculopathy', 'underdeveloped dorsal aorta', 'underlying condition', 'underutilization of aspirin', 'undiagnosed hypertension cases', 'uninfected individuals', 'uninfected patients', 'unique exposures', 'unleavened meat', 'unleavened meat, avoid fried', 'unrecognized CVD', 'unsuppressed HIV viraemia', 'uptake of this approach', 'urbanisation', 'useful dietary source of protein and fiber', 'variable factor', 'varieties', 'vascular and metabolic abnormalities', 'vascular endothelial growth factor (VEGF) expression', 'vasoprotective potential', 'vast heterogeneity', 'vegetable consumption', 'vegetable oils', 'vegetables serving', 'vegetative system', 'vessel sizes', 'viral replication', 'viral suppression', 'virologically suppressive antiretroviral therapy', 'virologically-suppressed people with HIV', 'vitamin C', 'waist circumference', 'waist-to-hip ratio', 'walnut consumption', 'water-soluble fraction', 'weight gain', 'weight maintenance', 'whole grains', 'with HIV', 'without clinical ASCVD', 'women', 'women aged 50-59 years', 'women and adolescents', 'women and men', 'women of childbearing age', 'women with HIV', 'women with a history of hypertensive disorders during pregnancy', 'women with breast cancer who have undergone therapy', 'women with such symptoms', 'women without angiographically obstructive coronary artery disease', 'work or family stress', 'world prevalence', 'worsen', 'year', 'year month date', 'years', 'young mice', 'young people', 'younger population', 'β blockers', '€ 192 billion', '≥ 7.5%', '≥140 and ≥90'], ['(60, 61)', 'data reaffirmed two years later'], ['(HbA1c)', '1 to 2.5h per week', '10 million people a year will die for smoking', '37% increased', '37.7% were obese', '4.1. Smoking', 'ACC and AHA', 'Already Present Disease', 'Anti-hypertensive', 'BMI ranges 20 to 25 kg/m2', 'BMI, Obesity, Abdominal thickness', 'Body Weight Regulation', 'CAD', 'CV risk', 'CVD morbidity', 'CVD mortality', 'Cardiology (ESC) Guidelines', 'Choice', 'Cigarette smoking', 'Counselling for cessation', 'Degree of AH', 'ESC Guidelines', 'Effects of obesity', 'Estimated total CVD risk', 'HERS trials', 'HRT', 'Harm', 'Healthy Lifestyle', 'Increased insulin resistance, Increased systemic inflammation and prothrombotic', 'Lifestyle intervention', 'Lower BP to 140/90 mmHg', 'Lower than 140/85 mmHg', 'Mediterranean diet supplemented with nuts', 'Moderate exercise', 'Modifiable', 'Mortality rate', 'Muscle strengthening activities', 'National Health and Nutrition Examination Survey (NHANES)', 'Nicotine replacement', 'Obesity', 'Perimenopausal women in their 40s and 50s with distressing vasomotor symptoms', 'Pharmacotherapy', 'Physical activity', 'Primary or secondary prevention of CVD', 'Secondary prevention cohort', 'Sedentary lifestyle, Bad nutrition habits', 'Smoking', 'Smoking Cessation', 'Smoking cigarettes', 'Total mortality', 'Treatment decisions', 'U.S. adults aged ≥ 20 years', 'USPSTF', 'Usage of HRT', 'Vigorous exercise', 'WHI findings', 'Women’s Health Initiative (WHI) study', 'adverse CV outcomes', 'affects women and men equally', 'ages of 2.5 to 5h a week', 'blood pressure in menopausal women', 'cardiomyocyte hypertrophic response', 'cardioprotective effects of estrogen', 'conflicting data', 'decline in', 'developing', 'elevated risk for CVD', 'encounter', 'estimated 1.6 billion smokers in the world', 'estrogen-progestin replacement', 'evidence for promoting', 'greatest contribution in the development of CVD', 'group', 'guidelines on CVD', 'healthy adults all ages', 'healthy adults sedentary lifestyle', 'heart disease-related causes', 'help the patient', 'hypertrophic response', 'individual advisory', 'intensity of the exercise', 'light exercise intensity', 'male smokers', 'managing variable CVD risk factors', 'measures', 'medication approaches', 'men smokers', 'menopause as a risk factor', 'metabolic syndrome', 'mortality due to heart disease-related causes in adults with DM', 'nitric oxide metabolism', 'oral isoflavone supplementation', 'patients coronary heart disease myocardial', 'pharmacotherapy options', 'physician', 'postmenopausal women', 'preventable risk factor', 'quick decision on further treatment', 'range from individual approaches through group therapies to medication approaches', 'recommendation', 'recommendations', 'redistribution of fat around the abdominal area', 'reduce', 'reduction in smoking', 'rise in smokers among women and adolescents in Europe', 'self-help technique', 'significant gender difference in type 1 DM', 'smoking cessation counseling', 'smoking cigarettes', 'soy isoflavone supplementation', 'therapies', 'two to four times higher than in those without DM', 'type 1 DM', 'vascular endothelial function', 'women smokers', 'women with type I DM'], ['10-year CVD risk', 'pooled cohort risk equation'], ['10: 113-23.', '2013 ESC Guidelines on diabetes, pre-diabetes and cardiovascular dis-eases', 'Adapted from the ESC Guidelines on diabetes, pre-diabets and cardiovascular dis-eases.', 'Almanah 2014: Globalno zdravlje i kardiovaskularne bolesti.', 'Cardiol Croat', 'ESC Pocket Guidelines', 'Eur Heart J 2013; 34(39): 3035-87.', 'J 1991; 121: 293-8.', 'Nascimento BR, Brant LCC, Moraes DN, Ribeiro ALP.', 'Perk J, De Backer G,', 'Ryden L, Grant PJ, Anker SD, et al.', '[6]', '[8]'], ['13 (4) 2017', 'HOPE-3 trial', 'JOURNAL.HOUSTONMETHODIST.ORG', 'REVIEW METHODIST DEBAKEY CARDIOVASC J', 'benefit occurs in both men and women', 'intermediate-risk subjects without known CVD', 'statins help in the primary prevention of CVD'], ['16 September 2016', 'Accessed date'], ['17% reduction', 'primary endpoint'], ['195 165 1·0', '2010–2011'], ['1992; 12: 911-9', '2011; 93: 684-8', '52. Mensink R, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.', '53. Shah M, Adams-Huet B, Garg A. Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials.', 'Am J Clin Nutr', 'Arterioscler Thromb'], ['1996–1999', '276 136 1·8'], ['1996–2011', '24 768 2803 268 165 1·4'], ['2000–2002 early cART era', 'era43 628 132 men 196 148·0 1·35'], ['2000–2003', '324 162 1·7'], ['2001 RCT', 'increased fruits and vegetables'], ['2002; 25:28–32', 'Food Review'], ['2003–2005 intermediate cART era', 'era51 007 205 men 229·5 133·4 1·74'], ['2004', '759', 'AIDS Investigators', 'AIDS Res Hum Retroviruses', 'Atenolol vs nonatenolol β-blockers for the treatment of hypertension', 'Brenchley JM', 'CD4+ T cell depletion', 'Can J Cardiol. 2014; 30(5 Supple):S47–S53.', 'HIV disease', 'Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey Smith G, Riemersma RA, Ebrahim SB. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev.', 'J Exp Med', 'Kuyper L, Khan NA. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.', 'L', 'PubMed: 19482214', 'PubMed: 24750981', 'R', 'Studio Cardiologico', 'gastrointestinal tract', 'pazienti affetti da AIDS'], ['2004; 92:311–319', 'Brit J Nutr'], ['2004–2007', '270 178 1·3'], ['2005; 81: 1322-9', 'Nutr'], ['2006–2009 late cART era 58 866 259 men 185·2 161·1 1·12', 'era58 007 205 men 229·5 133·4 1·74'], ['2007', '28(19):2375–414', 'Am J Med. 2002; 112(4):298–304', 'Ann Pharmacother. 2002; 36(12):1950–6', 'Bucher H', 'Carroll D', 'Evidence for the cardioprotective effects of omega-3 Fatty acids', 'Heart J', 'Hengstler P', 'Meier G', 'N-3 polyunsaturated fatty acids in coronary heart disease', 'PubMed: 11893369', 'PubMed: 12452760', 'PubMed: 17726041', 'Roth MT', 'Schindler C', 'a meta-analysis of randomized controlled trials'], ['2007; 357(12):1221–8', '[PubMed: 17881753]'], ['2007; 369:1090–8', '380: 581-90.', 'Burr M, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM', 'Effects of changes in fat, fish and fibre intakes on death and reinfarction: diet and reinfarction trial (DART). Lancet. 1989; 2(8666):757–61.', 'Endpoint analysis', 'GISSI-Prevenzione Trial', 'Lancet', 'PubMed: 17398308', 'PubMed: 2571009'], ['2008–2009', '245 167 1·3'], ['2010 ACCF/AHA Guideline', 'endorsed assessment of carotid intima-media thickness (CIMT)/plaque information on a carotid ultrasound'], ['2010; 104(4):664–80', 'Thromb Haemost.'], ['2010; 121:e1–e170', '[PubMed: 20048228]'], ['2012', '2012 Sep;153(9);4480-90', '2015 Nov;100(11);3975-4011', '3 to 5 times a week', '30 minutes', 'AMP-activated protein kinase', 'AMP:ATP ratio', 'AMPK', 'AMPK knockout mice', 'AMPK pathway', 'American Heart Association, Inc.', 'Angiotensin II cardiac hypertrophy', 'Angiotensin II–induced cardiac hypertrophy', 'Brian J. North, PhD', 'C elegans', 'CR', 'CR and resveratrol', 'CR in rodents', 'CR mimetics', 'Calcineurin degradation', 'Cardiac-specific SIRT1-overexpressing mice', 'Cardiomyocyte apoptosis', 'Cardiomyocyte hypertrophy', 'Cardiovascular development and disease', 'Catalase', 'Clinical Care', 'Coronary', 'Correspondence to', 'David A. Sinclair, PhD', 'Delayed age-dependent cardiomyopathies', 'Drosophila', 'Endocrine Society Clinical Practice Guideline', 'Endocrinology', 'Endothelial function', 'Estrogen', 'Estrogen receptor-dependent pathway', 'Estrogens', 'Extensive SIRT1 overexpression', 'FOXOs', 'Forkhead Transcription Factors', 'Forkhead transcription factors', 'Getting Back on Track', 'IGF-1', 'IGF-1 homologue', 'IGF-1 pathway', 'IGF-1 receptor–deficient mice', 'IGF-1 signaling', 'IGF-1 signaling cascade', 'IGF-1 signaling pathway', 'IGF-1/Growth Hormone', 'Insulin/IGF-1 pathway', 'Loss of telomeric DNA', 'Menopause', 'NAD+-dependent deacetylases and ribosyltransferases', 'NADPH:quinone oxidoreductase 1', 'NO', 'NO genes', 'Nfr2 stress response transcription factor', 'Oxidative stress, apoptosis, and cardiomyopathy', 'PI3K/AKT/mTOR pathway', 'Pressure overload-induced cardiac hypertrophy', 'ROS', 'Reactive oxygen species', 'Reduction of stress-induced apoptosis', 'SIRT', 'SIRT1', 'SIRT1 transgenic mice', 'SIRT3', 'SIRT7 knockout mice', 'Shc locus', 'Sirtuins', 'Src-homology 2 domain', 'TSC1/2', 'Treatment of Symptoms', 'UCP2', 'activity in vessels', 'adequate maintenance', 'adiposity', 'age-associated changes', 'age-dependent LV hypertrophy and diastolic dysfunction', 'age-related decline', 'aging', 'aging and cardiovascular research fields', 'aging effects on the fly cardiovascular system', 'aging field', 'aging pathways', 'aging research', 'angiogenesis', 'animal models of aging', 'arterial stiffness', 'assessing damaged nuclear and mitochondrial DNA', 'atherosclerosis and arterial stiffness', 'autocrine and paracrine effects', 'autophagy', 'before starting the exercise', 'benefit from low intensity exercise', 'better understanding of the link between aging and CVD', 'biogenesis', 'blocks the decline in', 'calorie restriction', 'cardiac function', 'cardiac hypertrophy', 'cardiac hypertrophy and failure', 'cardiac progenitor cell senescence', 'cardiac regeneration', 'cardiac stem cell reserves', 'cardiac tissue', 'cardiomyocyte apoptosis', 'cardiomyocyte loss', 'cardiomyocytes', 'cardiomyopathy, cardiac fibrosis, myocardial degeneration', 'cardioprotective during ischemia and reperfusion', 'cardiovascular aging', 'cardiovascular biology', 'cardiovascular health', 'cardiovascular system', 'cell growth', 'cell growth, proliferation, differentiation, and longevity.', 'cellular aging', 'cellular components', 'cellular composition', 'cellular defenses against aging', 'cellular functions', 'cellular polarity', 'cellular senescence', 'cellular sources for energy generation', 'cereal fiber, bran, and germ intake', 'challenged', 'changes in cardiovascular system', 'chronic immune activation', 'clk-1 inactivation', 'collagen-homology region', 'compensatory mechanisms', 'control', 'controlling mitochondria quality', 'coronary artery spasm', 'coronary patients', 'cytokines', 'damaged mitochondria', 'decrease in ROS', 'decrease in absolute number of cardiomyocytes', 'decrease in repopulation of cardiomyocytes', 'decreased resistance to oxidative stress', 'decreases DNA damage, necrosis, and apoptosis', 'decreases in VEGF secretion', 'deficiency in growth', 'degeneration', 'delayed by deletion of InR', 'deletion of InR', 'destruction of defective molecules and organelles', 'determining the intensity of exercise', 'diabetic cardiomyopathy', 'diastolic filling', 'die postnatally', 'diet high in calories without exercise', 'dietary fiber', 'dieting and exercise', 'diminished recovery of heart function after acute ischemic challenge', 'discovery and confirmation of various aging pathways', 'dying after birth', 'dysfunctional mitochondria', 'effects on cardiovascular health', 'elderly', 'encourages self-reliance and reduces depression', 'endothelial nitric oxide synthetase (eNOS)', 'endothelial senescence', 'endothelium and smooth muscle cells', 'energy generation', 'exercise', 'exercising', 'expression of factors like p53, p21, p16, senescence-associated β-galactosidase activity', 'gap', 'gene expression', 'genetics', 'glucose and lipid metabolism', 'glutathione S transferase', 'growth factors', 'health benefits', 'health of cardiovascular tissues', 'health span', 'heart', 'heaviest patients', 'heme oxygenase I', 'high energy–demanding tissues', 'histological techniques', 'history and discoveries', 'hydrogen peroxide', 'hypertrophy of vascular smooth muscle', 'hypoxia', 'immunoblotting', 'impairment of angiogenesis', 'important in primary and secondary CVD prevention', 'incidence of most age-related diseases', 'increase in apoptosis', 'increase in fibrosis', 'increased apoptosis and necrosis', 'increased flavonol intake', 'inflammation', 'inflammatory cardiomyopathy', 'insulin-like growth factor 1', 'insulin-like growth factor-1', 'ischemia', 'ischemia and reperfusion', 'key genes', 'knockout mice', 'lifespan', 'lifespan and age-related diseases', 'lifespan extension', 'lifespan regulation', 'liver-specific IGF-1 knockout', 'longevity', 'longevity genes', 'longevity network', 'longevity pathways', 'loss of p66shc', 'low intensity exercise', 'lower-limb ischemia', 'mTOR', 'mTOR activity', 'mTOR inhibitor', 'macromolecules', 'maintaining cardiovascular health', 'mammalian target of rapamycin', 'mammals', 'marker', 'matrix deposition following vascular injury', 'measuring senescence-associated β-galactosidase activity', 'merging together', 'metabolic sensor', 'mice', 'mice deficient in IGF-1', 'mitochondria', 'mitochondria in the aging heart', 'mitochondrial biogenesis', 'mitochondrial function', 'model organisms', 'moderate to high clinical risk', 'molecular biology of aging', 'molecular genetics', 'molecular mechanisms', 'negative feedback', 'new mitochondria', 'nitric oxide (NO)', 'nonmammalian models', 'notch signaling', 'novel pathways', 'nucleus', 'numerous signaling pathways', 'nutrient-poor conditions', 'obese and sedentary rodent', 'overview of changes', 'oxidant treatment', 'oxidative damage', 'oxidative stress in the vasculature', 'oxidative theory of aging', 'p38 kinase isoforms', 'p66shc', 'paraquat', 'pathway', 'peroxisomal catalase', \"person's age\", 'phosphotyrosine-binding domain', 'physiology of a lean animal', 'plays a central role in the pathogenesis of atherosclerosis', 'positive feedback', 'postmitotic', 'potent oxidant treatment', 'powerful use', 'preserves LV volume and function', 'pressure', 'prevented Angiotensin II–induced hypertrophy and apoptotic cell death', 'primitve cardiovascular system', 'processes and pathways', 'production of ROS', 'proliferation', 'prostanoids', 'protected mice from aortic lesions', 'quality control', 'quantifying levels of 8-oxoguanine', 'rapamycin', 'rapamycin treatment', 'rate and degree', 'rate of regeneration in the aged', 'reactive oxygen species', 'recent breakthroughs', 'recent work', 'redox enzyme modulating mitochondrial ROS', 'reduces heart failure', 'regular exercise', 'regulating lifespan', 'removal', 'repair', 'research area', 'respiratory failure', 'response to', 'resveratrol', 'resveratrol and metformin', 'risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus', 'rodents and humans', 'rudimentary heart and circulatory systems', 'secreting hormone', 'senescence', 'sirtuin', 'sirtuin members', 'sirtuin-mediated deacetylation', 'sirtuinNorth', 'sirtuins', 'small molecules', 'smooth muscle cell proliferation', 'splice variant', 'stimulus-dependent manner', 'stress and cell death', 'systemic tissue homeostasis', 'telomere attrition', 'therapeutic approaches', 'tissue', 'tuberous sclerosis complex 1/2', 'uncoupling protein 2', 'under the supervision of experts', 'unique N-terminal region', 'various nonmammalian models', 'vascular adhesion molecules', 'vascular aging', 'vascular development', 'vascular growth factors', 'vascular response to ischemic conditions', 'ventricular dilation, hypertrophy, and diabetic cardiomyopathy', 'water and oxygen', 'weight loss', 'whole-grain', 'worms and flies', 'yeast to mammals', 'zebrafish', 'zebrafish and in mice'], ['2017 ESC Guidelines', 'document title'], ['21% reduction in cardiovascular disease events and mortality', 'series of prospective cohort studies'], ['22404725', '28684641', 'J Am Heart Assoc 2017', 'J Viral Hepat 2012', 'Lee SA, Sinclair E, Hatano H, et al.', 'Wang H, Peng G, Bai J, et al.', 'cardiovascular disease (ischaemic heart disease, stroke, and cardiovascular death)', 'cytomegalovirus infection', 'hepatitis C virus infection', 'impact of HIV on CD8+ T cell CD57 expression', 'meta-analysis of prospective studies up to 2016', 'population-based cohort study'], ['24: 97-1003', '316 099 white men', '54(14): 1209-27', 'Eur Heart J 2003', 'J Am Coll Cardiol 2009', 'Multiple Risk Factor Intervention Trial (MRFIT)', 'Neaton JD, Wenthworth D', 'Research Gorup', 'SCORE project', 'Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease', 'Value and limitations of existing scores for the assessment of cardiovascular risk', 'risk of fatal cardiovascular disease in Europe'], ['25-30 g per day from whole foods', 'Total Dietary Fiber Intake'], ['25: 245-52', 'Nutr Metab Cardiovasc Dis 2015'], ['27 cases', 'study of 27 cases'], ['3 components', 'Prevention strategy'], ['3.9% prevalence', 'People aged 40–49 years'], ['30% in people with HIV who had moderate hypertension', 'mild hypertension'], ['32%', 'high primary limb amputation rate'], ['32: 2143-52', 'Eur Heart J 2011'], ['34. Moyer V A; U.S. Preventive Services Task Force', 'Ann Intern Med.'], ['35. Ridker PM, Danielson E, Fonseca FA, et al.; JUPITER Study Group', 'N Engl J Med.'], ['36% 5-year mortality rate', 'nurse-led programme'], ['45%', 'successful linkage to care'], ['4S', 'Kjekshus J, Pedersen TR'], ['5. 200g of fruit a day', '6. 200g vegetables a day', 'Alcoholic beverages: 1 glass per day (women)', 'Alcoholic beverages: 2 glasses a day (men)', 'Other risk Factors, Asymp-tomatic Organ Damage or Disease', 'SBP 130-139', 'SBP 140-159', 'SBP 160-179', 'SBP ≥'], ['5.6 -6.9mmol/l', 'glucose after 2h of the meal <7.8mmol/l'], ['52 countries', 'included in the study'], ['54. Howard B, Kritchevsky D. Phytochemicals and cardiovascular disease.', 'A statement for healthcare'], ['58,970 participants', '83,527 participants', 'Alonso et al (2019) study', 'Althoff et al (2015) study', 'Danish HIV cohort', 'Hazard ratio 1.76', 'Incidence rate ratio 2.02', 'Infarction incidence rate', 'Infarction incidence rate 1.40', 'Mid-50s Acute myocardial infarction', 'Rasmussen et al (2015) study', 'Ratio 1.40', 'Truven Health MarketScan Commercial Claims and Encounter databases', 'USA Veterans Aging Cohort Study'], ['58–70', 'Maturitas 2018'], ['62% greater risk', 'Heart Failure (THESUS-HF)'], ['65 and older age group', 'average lifespan of humans'], ['69QRISK2', 'patients aged >40 years'], ['80 mg atorvastatin', 'Recommend all medications to be reviewed'], ['81: 552–61', 'Association between', 'Capabilities, opportunities and motivations for integrating evidence-based strategy for hypertension control into HIV clinics in southwest Nigeria', 'Iwelunmor J, Ezechi O, Obiezu-Umeh C, et al.', 'J Acquir Immune Defic Syndr', 'J Acquir Immune Defic Syndr 2019', 'PLoS One 2019; 14: e0217703', 'PubMed: 31045649', 'PubMed: 31170220', 'Shang C, Lee HM, Chaloupka FJ, Fong GT, Thompson M, O’Connor RJ.', 'retrospective cohort study'], ['90 countries', 'Population-based studies'], ['<140/85mmHg', '<2.5mmol/l', '<6.5% HbA1c', 'AH treatment', 'Avoid hypoglycemia', 'Dis-ease management and treatment', 'ESC/EASD', 'First line of DM treatment', 'Guidelines on diabetes in order to prevent CVD', 'HbA1c target', 'Healthy living habits', 'Increase body weight', 'Intensive treatment of hypertriglyceridemia', 'LDL target', 'Metformin', 'Multidisciplinary approach', 'Patient centres', 'People with DM do not evaluate their risk', 'Recommendations', 'Reduce CVD risk', 'Reduce microvascular events', 'SCORE table', 'Statins therapy', 'Target BP'], ['A combination of several factors result in much higher total risk', 'SCORE system help to es-timate total risk'], ['A study by Hookana E, Junttila MJ, Puurunen VP, et al.', 'Heart Rhythm 2011; 8: 1570–75'], ['A study by Nugent R, Barnabas RV , Golovaty I, et al.', 'AIDS 2018; 32 (suppl 1): S83–92'], ['ACE-inhibitors', 'blockers'], ['ADA', 'Expert Committee for the Prevention of the CVD', 'WHO', 'criterion'], ['AHA Guidelines', 'Diets high in fiber'], ['AHA guidance', 'cardiovascular risk scores'], ['AHA scientific statement', 'heart failure examination and therapy'], ['AHA scientific statement on HIV', 'Intervention', 'Traditional', 'atherosclerotic cardiovascular disease risk factors', 'cardiovascular disease risk elevation', 'current CD4 count', 'lifestyle optimisation regardless of risk', 'non-traditional atherosclerotic cardiovascular disease risk factors', 'pharmacotherapy with rosuvastatin, atorvastatin, pravastatin, or pitavastatin', 'risk adjustment approach'], ['AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort', 'median age'], ['AMP-activated kinase (AMPK)', 'AMP-activated kinase (AMPK),', 'and nicotinamide adenine dinucleotide (NAD)+-dependent deacetylases (sirtuins).', 'insulin/insulin-like growth factor 1 (IGF-1)', 'mammalian target of rapamycin (mTOR)', 'nicotinamide adenine dinucleotide (NAD)+-dependent deacetylases (sirtuins)', 'regulatory” pathways', 'the mammalian target of rapamycin (mTOR),', 'which include insulin/insulin-like growth factor 1 (IGF-1),'], ['APO B', 'alternative marker (mixed dyslipidemia, diabetes, metabolic syndrome, chronic kidney disease).'], ['ART increasing uptake', 'US-based longitudinal analysis'], ['ART non-adherence', 'Cytomegalovirus', 'Cytomegalovirus co-infection', 'Depression', 'Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML', 'Heart disease', 'Hepatitis C', 'Increased HIV risk', 'Increased heart failure risk', 'Kupffer cells', 'Liver fibrosis', 'Microbial translocation', 'NHANES I study', 'Underlying mechanisms', 'Unhealthy alcohol consumption', 'antecedent to heart disease', 'chronic inflammation, endothelial dysfunction, exacerbating microbial translocation through hepatic damage', 'common co-infections among people with HIV', 'heart failure among people with HIV', 'incident cardiovascular disease events', 'risk factor for cardiovascular disease', 'women with depression had a higher relative risk of CAD incidence compared to women without depression'], ['ASCV', 'HIV specific therapies', 'anti-inflammatory strategies', 'atherosclerotic cardiovascular disease', 'attention should be paid to', 'disease risk factors', 'sex-based differences in response to HIV', 'strategies to lower inflammation'], ['ASCVD benefit', 'intensive versus standard glycemic control'], ['ASCVD: atherosclerotic cardiovascular disease', 'BMI: body mass index'], ['Abnormal coronary vasomotion', 'Prognostic indicator for cardiovascular events in women'], ['Accessed', 'DqZbRxfzlYtLg/Monitoring-Guidelines.pdf'], ['Achieved blood pressure levels', 'Achived blood pressure levels', 'Baseline blood pressure levels', 'Blood pressure lowering', 'Different baseline blood pressure levels', 'Effects of blood pressure lowering', 'Outcome incidence in hypertension'], ['Achivement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe', 'EURIKA study'], ['Acquired immunodeficiency syndrome', 'Cardiac involvement'], ['Adjudicated heart failure', 'Hazard ratio 2·10 (1·38–3·21)'], ['Adult humans', 'meta-analysis of randomized placebo-controlled trials'], ['Advantages', 'Food groups'], ['Affected individuals', 'Depression and heart disease', 'Men and women'], ['Africa in 2018', 'cardiac arrhythmia services'], ['Aging', 'Aging and cardiovascular research', 'Cardiovascular disease (CVD)', 'Cardiovascular risk factor', 'Cardiovascular system', 'Delivering oxygenated blood', 'Effect on heart', 'Fundamental mechanisms of aging', 'Health of every tissue', 'Increased risk of health complications and disease', 'Other risk factors', 'Progressive decline in physiological processes', 'Understanding', 'leading cause of mortality'], ['Agu CE', 'Uchendu IK'], ['Aim', 'Summary'], ['Akt', 'protein kinase B'], ['Albuminuria', 'Dyslipidemia'], ['Alcohol', 'Improves lipid profiles, BP, (+/−) ROS, and endothelial function'], ['Alexander KP', 'Arterioscler Thromb V asc Biol.', 'Hammill BG', 'JAMA.', 'Kim ESH', 'Lee PY', 'Menon V', 'Pasquali SK', 'Peterson ED', 'Representation of elderly persons and women in published randomized trials of acute coronary syndromes', 'Status of women in cardiovascular clinical trials'], ['All authors', 'data acquisition, analysis, and interpretation'], ['All health care professionals', 'Public Health'], ['All rights reserved', 'copyright'], ['All stroke Odds ratio', 'Tanzania and urban Dar-es-Salaam'], ['All-cause mortality', 'Vascular events'], ['Altered glucose and lipid metabolism', 'Cardiac myopathy', 'Cardiovascular health', 'Impaired left ventricular function', 'Less detrimental effects on cardiovascular health', 'Low-income settings', 'Mitochondrial toxicity', 'Older ART regimens', 'Other regimens', 'Side-effect profiles', 'Unclear', 'Whether these cardiotoxic-ART effects differ by sex'], ['Alternative risk factors (mixed dyslipidemia, diabetes, metabolic syndrome, chronic kidney disease).', 'Non HDL cholesterol'], ['Am J Clin', 'Published'], ['American Heart Association Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Hypertension, Council on Lifestyle and Cardiometabolic Health, and Council on Quality of Care and Outcomes Research', 'McSweeney JC, Rosenfeld AG, Abel WM, et al.'], ['Amest dwarf mice', 'Mutations in Prop-1', 'Prop-1', 'Prophet of Pit-1', 'deficiencies of growth hormone, prolactin, and thyroid-stimulating hormone', 'growth hormone deficiencies', 'prophet of Pit-1', 'secondary hypogonadism'], ['Anderson GL', 'Assaf AR', 'Bassford T', 'Beresford SA', 'Black HR', 'Brunner RL', 'Brzyski RG', 'Caan B', 'Chlebowski RT', 'Gass M', 'Granek I', 'Greenland P', 'Hays J', 'Heber D', 'Heiss G', 'Hendrix SL', 'Hubbell FA', 'Johnson KC', 'Kotchen JM', 'Snetselaar LG', 'Stevens VJ', 'Tinker LF', 'Trevisan M', 'Vitolins MZ'], ['Angina', 'Burr M, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC'], ['Ann Intern Med 2016; 164: 23–29', 'sudden cardiac arrest'], ['Annual screens', 'those with cardiovascular disease'], ['Antidepressants', 'Substitution therapy with nicotine'], ['Antioxidant activity', 'Grains'], ['Apparently healthy adults', 'without signs of CVD, Diabetes Mellitus (DM), chronic kidney dis-ease, familial hypercholesterolemia'], ['Applicable guidelines', 'HbA1c of < 7%'], ['Asia Pacific Cohort Study Collaboration (APCSC)', 'Circulation 2005; 112: 3384-90'], ['Aspirin', 'Primary and secondary prevention of vascular disease'], ['Assessment of left ventricular ejection fraction', 'Revascularisation'], ['Astrup A, Dyerberg J, Elwood P, et al.', 'The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010'], ['Auditable targets', 'patients with a smoking history'], ['Available in PMC', 'October 13'], ['BHIV A guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals (2019 interim update). 2019', 'British HIV Association', 'guidelines (2019 interim update)', 'https://www.bhiva.org/file/'], ['BMI >35 kg/m2 with comorbidities', 'BMI >40 kg/m2', 'bad lifestyle habits changes', 'blood plasma lipids', 'cholesterol and triglycerides', 'high risk group', 'lifestyle changes', 'lipoproteins associated with proteins (apolipo-proteins)', 'pharmacotherapy (orlistat)', 'pharmacotherapy (orlistat) or bariatric surgery', 'unsuccessful in long-term treatment'], ['BMJ. 2011; 342:d671', 'Eur Heart J. 2012; 33(4):505–14', 'PubMed: 22041554', 'Ronksley P, Brien SE, Turner BJ, Mukamal KJ, Ghali WA', '[PubMed: 21343207]', 'angiotensin receptor blockers', 'association of alcohol consumption with selected cardiovascular disease outcomes', 'beneficial in normotensive atherosclerotic patients', 'collaborative meta-analysis of randomized trials'], ['BP target', 'individuals aged 60 years and older without diabetes or chronic kidney disease'], ['Balanced variety', 'Calorically sensible'], ['Baylor College of Medicine', 'Conflict of Interest Disclosure', 'Dr. Nambi', 'Merck', 'Roche', 'Sanofi-Regeneron', 'Siemens Healthcare Diagnostics'], ['Benson Njuguna, BPharm', 'Moi Teaching and Referral Hospital, Eldoret, Kenya'], [\"Blood Pressure Lowering Treatment Trialists' Collaboration\", 'Sund-strom J, Arima H'], ['Blood Pressure Reduction', 'Fish Oil Supplementation'], ['Bourgi K', 'Greater weight gain in treatment naïve persons starting dolutegravir-based antiretroviral therapy'], ['Breast cancer', 'Cardiac morbidity', 'Cardiac mortality', 'Radiation therapy'], ['Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection.', 'Nat Med 2006; 12: 1365–71'], ['BubR1', 'budding uninhibited by benzimidazoles related 1', 'develop normally', 'develop premature aging phenotypes', 'heterozygous mice', 'homozygous BubR1 hypomorphic mice', 'inhibitor of the anaphase-promoting complex', 'positioning this pathway', 'regulating the mitotic spindle assembly checkpoint', 'serine/threonine protein kinase', 'vital mediator of aging and the cardiovascular system'], ['BubR1 hypomorphic mice', 'Cardiovascular Aging Review Series', 'adiposity of cardiac tissue', 'arrhythmias', 'arterial wall thickness', 'death', 'elastic properties', 'events', 'fibrosis', 'histological methods', 'inner diameter', 'loss-of-BubR1 mice', 'mechanisms by which aging and obesity reduce cardiovascular function', 'role'], ['CAC: coronary artery calcium', 'CIMT : carotid intima–media thickness'], ['CD4 cell count', 'improved HIV treatment uptake and related continuous improvement'], ['CD4+ T-cell count', 'Conservative surgical approaches', 'HIV control', 'Important intervention point', 'Little availability', 'Lower CD4 counts', 'Patients with AIDS', 'Smoking rates', 'Standard surgical techniques'], ['CKD: chronic kidney disease', 'hs-CRP: high-sensitivity C-reactive protein'], ['CLK-1', 'clock 1'], ['CT-based coronary calcium score (CAC)', 'threshold for initiating statin therapy'], ['CV mortality and nonfatal myocardial infarction', 'reduction of LDL cholesterol'], ['CVD are multifactorial', 'multifactorial'], ['CVD benefit', 'SGLT-2 inhibitors'], ['CVD in women', 'cardiac radiation dose-volume', 'ischemic heart disease'], ['CVD incidence and their consequences', 'Prevention of CVD'], ['CVD including atherosclerosis, hypertension, myocardial infarction, stroke', 'aging cardiovascular tissues', 'arterial system', 'health of the arterial and cardiac', 'pathological alterations including hypertrophy, altered LV diastolic function, diminished LV systolic reverse capacity, increased arterial stiffness, impaired endothelial function3,4'], ['CVD is the product of more than 1 risk factors', 'The second'], ['CVD morbidity and mortality', 'Variable risk factors', 're-duce'], ['CVD risk assessment', 'HIV-related cardiovascular disease risk-enhancing factors', 'SCORE table not implemented', 'clinicians', 'especially important in the quick CVD assessment', 'government policies', 'lack of time in work with a patient', 'local community polices', 'over-burdening physicians, insufficient number of cardiologists', 'prevention measures need to be more intense', 'quick CVD assessment', 'through information technology'], ['CVD risk factors or target organ damage', 'Diabetics'], ['CVD risk protocols', 'HDL Cholesterol (HDL-C)', 'Low Density Lipoprotein (LDL)-Cholesterol (LDL-C)', 'Total Cholesterol (TC)', 'Triglycerides (TG)', 'lipid analysis'], ['Camm AJ', 'Camm AJ, Luscher TF, Serruys PW', 'Circ.ahajournals.or/ content/124/23/2560', 'Global preventive policies. Strategies at European and worldwide level.', 'Kotseva K', 'Luscher TF', 'Online Referencing, http://circ.ahajournals.or/content/124/23/2560 (accessed 12 September 2016).', 'Online Refrencing, http://www.revespcardiol.', 'Oxford: Blackwell, 2006', 'Pearson TA', 'Public policy approaches to the prevention of heart disease and stroke', 'Serruys PW', 'The ESC Textbook of Cardiovascu-lar Medicine', 'http://www.revespcardiol.'], ['Cardiol 1990; 66: 203–06', '[PubMed: 2371952]'], ['Cardiology Reviews, 2018', 'Eur Heart J 2012', 'European Society Cardiology', 'Fifth Joint Task Force', 'Other Societies on Cardiovascular Disease Prevention', 'Risk factor Detection and Modification'], ['Cardiometabolic risk', 'older adults with multiple co-morbidities in rural South Africa'], ['Cardiovascular Disease (CVD) Prevention', 'Health Care Professionals'], ['Cardiovascular Diseases (CVDs)', 'Keywords: Mortality and morbidity'], ['Cardiovascular adaptions', 'Differences', 'Electrocardiographic findings Women have a longer corrected QT interval than men. Women have a shorter PR interval than men.', 'Table 1. Differences in clinical parameters and manifestations in women compared to men.', 'Women have an increased pulse rate with increased cardiac output versus men, who have higher blood pressure in response to high stress.'], ['Cardiovascular benefits', 'Omega-3 fatty acids', 'Widely studied'], ['Cardiovascular disease in women living with HIV', 'Solomon D'], ['Cardiovascular disease morbidity and mortality', 'Reduction'], ['Cardiovascular disease risk reduction in HIV', 'Sub-Saharan Africa and low-income and middle-income countries'], ['Cardiovascular diseases', 'leading cause of morbidity and mortality'], ['Cardiovascular diseases (CVD) and HIV', 'Feasibility of integrated, multilevel care'], ['Cardiovascular risk factors', 'Walnut consumption'], ['Cardiovascular risk prediction functions', 'Underestimate risk in HIV infection'], ['Care delivery for heart failure', 'Task redistribution'], ['Carotid artery', 'Estradiol', 'Estrogen receptor-alpha', 'Estrogen receptor-beta', 'Reendothelialization'], ['Categorization into different groups of total CVD risks', 'initial risk level'], ['Changes in diet and lifestyle', 'Long-term weight gain'], [\"Cholesterol Treatment Trialists' Collaboration\", 'Mihaylova B, Em-berson J, Blackwll L, et al.'], ['Cholesterol and Recurrent Events (CARE)', 'studies [45]'], ['Chronic care services', 'Comprehensive primary care', 'HIV programs', 'Scaling up chronic care systems', 'comprehensive primary care', 'noncommunicable disease services', 'rural Malawi'], ['Cigarette consumption', 'International Tobacco Control Policy (ITC) Project', 'Tax structure'], ['Circ Arrhythm Electrophysiol 2016; 9: e003723', 'absence of previously identified heart disease'], ['Clinical studies', 'Framingham, Multiple Risk Factor Intervention Trial (MRFIT) [21], Asia Pacific Cohort Studies Collaboration (APCSC) [22], INTERHEART [23]'], ['Clinical trial data', 'Lack of gender-specific analysis'], ['Clinical trials', 'Enrollment of women'], ['Cohort studies', 'Fish consumption and coronary heart disease mortality'], ['Collaborative meta-analysis', 'Individual participant data from randomized trials'], ['Committee for Practice Guidelines', 'European Society for Vascular Surgery', 'European Society of Cardiology'], ['Congestive heart failure', 'Hazard ratio 1·41 (1·29–1·54)'], ['Consideration of electrophysiology and an implantable cardiac defibrillator', 'Reducing the risk of sudden cardiac death'], ['Constrictive pericarditis', 'Dose volume of exposure to the heart', 'Increased risk of cardiovascular mortality', 'Myocardial fibrosis', 'Radiation injury', 'Valvular and coronary artery lesions'], ['Controlled trial', 'Dietary advice to men with angina'], ['Coronary heart disease', 'Dietary fat types', 'Smoking cessation', 'online resources'], ['Coronary heart disease mortality', 'Fish consumption'], ['D:A:D international prospective multicohort study', 'Lancet HIV 2018'], ['DM', 'high risk', 'increased levels of fat in the blood (cholesterol, triglyceride)'], ['DNA damage', 'phosphorylation status of γ-H2Ax'], ['Danish HIV Cohort Study', 'Rasmussen et al (2015)'], ['De Backer G', 'Perk J'], ['Department of Health Republic of South Africa', 'Lipid and Atherosclerosis Society of Southern Africa (LASSA)', 'National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults', 'South African Heart Association (SA Heart)'], ['Diabetes mellitus', 'HbA1c'], ['Diagnosis and monitoring', 'important estimate of variable risk factors'], ['Diet and exercise', 'Hyperlipidemia'], ['Diuretics, renally-excreted β blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor', 'medications used in heart failure treatment'], ['EACPR', 'European Assoccia-tion for Cardiovascular Prevention&Rehabilitation', 'Gohlke H'], ['ECG', 'treadmill bicycle exercise'], ['ECG and blood pressure monitoring', 'blood pressure monitoring'], ['EP', 'electrophysiology'], ['ESC Committee for Practice Guidelines (CPG)', 'European Association for Cardiovascular Prevention & Rehabilitation (EACPR)'], ['EVERLAST study', 'PubMed: 31796103'], ['Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.', 'Mensink RP, Katan MB'], ['Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomized controlled trial', 'John J, Ziebland S, Yudkin P, Roe LS, Neil HAW, Oxford Fruit and Vegetable Study Group'], ['Effects of omega-3 fatty acid on major cardiovascular events and mortality in patients with', 'Wen YT, Dai JH, Gao Q'], ['Eggs', 'NC Controversial data without mechanistic evidence'], ['Eighth Joint National Committee', 'Evidence-based guideline', 'February 5;311(5):507-20.', 'JAMA', 'JNC 8', 'James PA, Oparil S, Carter BL, et al.', 'Management of high blood pressure in adults', 'panel members appointed', 'the Eighth Joint National Committee'], ['Elderly people', 'Proven CVD'], ['Electrophysiological evaluation', 'Individuals who have ischaemic heart disease'], ['Elsevier Inc', 'Publisher'], ['Engaging the entire care cascade in Western Kenya', 'Engaging the entire care cascade in Western Kenya: a model to achieve the cardiovascular disease secondary prevention roadmap goals.', 'Glob Heart 2015; 10: 313–17.', 'Models of integration of HIV and non-communicable disease', 'Njuguna B, Vorkoper S, Patel P, et al.', 'PloS One 2012; 7: e43400.', 'PubMed: 22916256', 'Vedanthan R, Kamano JH, Bloomfield GS, Manji I, Pastakia S, Kimaiyo SN', '[PubMed: 26704963]', 'campaigns', 'campaigns for non-communicable diseases', 'cardiovascular disease secondary prevention roadmap goals', 'entire care cascade in Western Kenya', 'non-communicable diseases', 'rural Uganda'], ['Erk', 'extracellular signal-regulated kinase'], ['Eur Heart J 2013', 'THESUS-HF registry'], ['Europe, state, region and local community', 'population strategy'], ['European AIDS Clinical Society Guidelines Version 9·1 (2018)', 'Framingham score every two'], ['European Guidelines for Diabetes (ESC/EASD)', 'establish'], ['European Society of Cardiology (ESC) Guidelines', 'recommendations are based on'], ['European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice', 'Fourth Joint Task Force'], ['European study', 'showed that coronary heart disease risk factor burden is high'], ['Evaluating Pimobendan In Cardiomegaly (EPIC)-Heart study', 'population-based evidence'], ['Evaluation of vascular event risk while on long-term anti-retroviral suppressive therapy', 'Sarfo FS, Nichols M, Gebregziabher M, et al.'], ['Exercise', 'Mortality outcomes'], ['Ezetimibe', 'Statin'], ['FIB-4 stage of liver fibrosis', 'incident heart failure'], ['FOXO', 'forkhead transcription factors'], ['FOXO factor', 'FOXO3a deficiency', 'cardiomyocyte size', 'eNOS expression', 'postnatalNorth and Sinclair Page 6'], ['FOXO factors', 'longevity network in cardiovascular tissues'], ['FOXO family', 'vessel formation and maturation'], ['FOXO/sirtuin factors', 'age-related impairment of angiogenesis', 'angiogenesis impairment', 'downstream effector pathway', 'end-organ damage seen in the elderly', 'endothelial dysfunction', 'hypoxic responses', 'vascular flow', 'vessel wall remodelling'], ['FOXOs/sirtuins', 'mitochondrial signaling pathway'], ['Fiber', 'Fruit', 'Healthy food', 'Marine omega-3 fatty acids', 'Mediterranean type of nutrition', 'Polyunsaturated fatty acids', 'Salt', 'Saturated fatty acids', 'Transfat acids', 'healthy nutritional recommendations'], ['Fibrates (107)', 'aspirin (108)', 'beta-blockers (109)', 'diet as a whole (106)', 'fruits and vegetables (59, 61, 62)', 'improved physical activity (102)', 'omega-3 fatty acids (110)', 'renin-angiotensin system blockade (104)', 'smoking cessation (103)', 'standard medical therapies', 'statins (100, 101)'], ['Fish intake', 'Meta-analysis of observational studies'], ['Fontaine stage III or IV', 'advanced stage vascular disease'], ['Food synergy', 'nutrition'], ['Framingham risk scores', 'coronary heart disease risk assessment recommended'], ['Framingham risk tables', 'HIV-infected black South Africans'], ['Framingham score', 'men (>40 years) and women (>50 years)'], ['Fruits and Vegetables', 'improving cardiovascular health'], ['Functional recovery', 'Longterm mortality', 'Patients', 'Socioeconomic status', 'Surviving acute myocardial infarction'], ['Further RCT evidence', 'supports the use of a Mediterranean diet'], ['Further studies', 'dietary regimens, AMPK, and cardiovascular health'], ['GI', 'Glucose intolerance'], ['GI cases', 'modify lifestyle habits'], ['GUK starving', 'glucose after 2h of a meal'], ['Garlic', 'Improves lipid profiles'], ['Gertrud Siegenthaler Foundation', 'Lloyd-Jones D', 'References', 'Swiss foundation for medical-biological scholarships (SSMBS; SNSF No PASMP3_132551)', 'Systematic review and meta-analysis', 'University of Zurich'], ['Gestational Diabetes', 'Gestational diabetes mellitus (GDM)'], ['Gilead Sciences and Merck', 'Global Health Catalyst (Africa Non-Communicable Diseases Open Lab)', 'apply to the journal', 'content affected', 'copyediting', 'errors discovered', 'final approval', 'grants', 'honoraria', 'legal disclaimers', 'manuscript', 'outside the submitted work', 'production process', 'proof review', 'typesetting'], ['Global disparities', 'Hypertension prevalence and control'], ['Global, regional, and national burden of stroke', 'Systematic analysis for the Global Burden of Disease Study 2016'], ['Government-operated stroke units', 'available', 'brain imaging', 'clustered in South Africa, Nigeria, and Ghana', 'commonplace in sub-Saharan Africa', 'complex management and rehabilitation', 'denial of a stroke', 'early admission to a stroke unit', 'financial constraints', 'individuals with haemorrhagic stroke', 'more frequent factors encountered in sub-Saharan Africa', 'provided', 'saves lives and reduces disability', 'sociocultural factors', 'stroke units'], ['Group therapy', 'Individual advisory'], ['HDL-C: high-density lipoprotein cholesterol', 'LDL-C: low-density lipoprotein cholesterol'], ['HIV and hypertension', 'integrated care'], ['HIV and non-communicable diseases', 'HIV treatment program in eastern Uganda', 'Integrated hypertension and HIV care cascades', 'healthcare services', 'older South Africans'], ['HIV burden', 'opinions'], ['HIV care', 'coronary heart disease care', 'lifestyle modification'], ['HIV guidelines', 'Infectious Diseases Society of America HIV Guidelines (2013)'], ['HIV infected individuals', 'cardiovascular mortality'], ['HIV life expectancy', 'promising outcomes of therapies'], ['HIV or AIDS', 'Human immunodeficiency virus', 'PubMed searches', 'References for this Review', 'Search strategy and selection criteria', 'acquired immunodeficiency syndrome', 'types of cardiovascular disease'], ['HIV services', 'cardiovascular disease risk factor screening'], ['HIV treatment uptake', 'absolute rates of cardiovascular disease mortality'], ['HIV-associated cardiomyopathy', 'causes'], ['HIV-infected brain', 'improve ischemic stroke outcome'], ['HIV-infected cells', 'inflammatory microenvironment'], ['HIV-related factors', 'calculated risk estimate'], ['HIV-specific calculators', 'alternatives'], ['HRT for treatment of menopausal symptoms', 'women under age 50'], ['Harvard University Press; Cambridge, MA: 1980', 'Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease'], ['Heart Association Task Force on Clinical Practice Guidelines', 'J Am Coll Cardiol 2017'], ['Heart Protection Study Collaborative Group', 'MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536'], ['High taxes on all tobacco products', 'children in schools', 'healthy life-style habits', 'media campaigns', 'noxiousness smoking lectures', 'public health measures and legislation', 'smoking ban', 'tobacco tax', 'youth smoking'], ['High-income countries', 'research on thrombotic risk reduction strategies for HIV'], ['Higher fruit consumption linked with lower body mass index', 'Lin B, Morrison RM'], ['Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV', 'cardioprotective strategies and ω-3 fatty acids in perspective'], ['Hospitalised patients', 'Ischaemic heart disease'], ['How to seven countries study contibuted to the definition and development of the Mediterranean diet concept: A 50-year journey', 'Menott A, Puddu PE'], ['Hunter DJ, Reddy KS', 'Noncommunicable diseases'], ['IGF-1 pathways', 'MAPK and mTOR pathways', 'cell growth, proliferation, and survival', 'complex picture', 'lifespan extension in C elegans', 'lipid and glucose metabolism', 'loss of insulin-like growth factor 1 (IGF-1) signaling', 'recent data', 'role of IGF-1 in cardiac function and aging', 'unknown'], ['INTERHEART', 'major inter-national clinical study'], ['Implantable cardiac defibrillator', 'Individuals with particular infiltrative conditions'], ['Improved glucose metabolism, reduced inflammation, ROS, lipid profiles, and blood pressure', 'Whole Grains'], ['In Rwanda', 'Nurses have been successfully deployed'], ['Increased consumption of fruit and vegetables', 'reduced risk of coronary heart disease'], ['Increased systemic inflammation', 'prothrombotic effect'], ['Increasing incidence of ischemic stroke in patients with HIV infection', 'Ovbiagele B, Nath A'], ['Individual components', 'Observational versus RCT data'], ['Influence of baseline lipids on effectiveness of pravastatin in the CARE trial', 'cholesterol and recurrent events'], ['Influence of baseline lipids on effectiveness of pravastatin in the CARE trial cholesterol and recurrent events', 'J Am Coll Cardiol 1999; 33: 125-30'], ['Ingredient', 'Single mechanism'], ['International Classification of Diseases and Related Health Problems -11', 'oversight to be rectified'], [\"Iowa Women's Study\", 'Nurses Health Study'], ['J Am Diet Assoc. 2007; 107:1599–611.', 'dietary fatty acids'], ['JAMA Cardiol 2016', 'veterans aging cohort study'], ['JUPITER Study Group', 'Ridker PM, Danielson E, Fonseca FA, et al.'], ['JUPITER trial', 'LDL-C < 130 mg/dL', 'brachial index', 'individuals with a C-reactive protein > 2 mg/dL', 'statins in prevention', 'therapies for primary prevention of CVD', 'treatment decisions', 'uncertainty'], ['Jacobs DJ, Meyer KA, Kushi LH, Folsom AR', 'Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women’s Health Study. Am J Clin Nutr. 1998; 68(2):248–57.'], ['Junttila MJ, Hookana E, Kaikkonen KS, Kortelainen ML, Myerburg RJ, Huikuri HV', 'Temporal trends in the clinical and pathological characteristics of victims of sudden cardiac death in the'], ['Kaiser Permanente Southern California and Northern California, USA', 'Marcus et al (2014)'], ['Katan MB', 'Mensink R'], ['Ki67 or proliferating cell nuclear antigen', 'Regenerated cardiac tissue', 'Regenerative capacity', 'alterations in their', 'cardiac stem cells', 'long-lived or short-lived progeroid animal models', 'proliferation markers', 'proliferative index', 'small incompletely differentiated cardiomyocytes'], ['LDL C', 'therapy response'], ['LDL C and TC', 'non HDL C / HDL C'], ['LV', 'MCLK1', 'left ventricle', 'mammalian clock 1'], ['LV diastolic filling rate', 'begins to decline'], ['LV hypertrophy and fibroblast proliferation', 'increase in arterial stiffness'], ['Lancet. 2002; 359(9322):1969–74', '[PubMed: 12076551]'], ['Leeuwenburgh, Marzetti, and colleagues', 'mitochondrial dysfunction and deregulated autophagy'], ['Legume consumption and risk of coronary heart disease in US men and women', 'NHANES I Epidemiologic Follow-up Study'], ['Lessons from the NHLBI WISE study', 'Myocardial ischemia in women'], ['Lifestyle habits and environmental factors', 'Population strategy', 'Prevention of the occurrence or reoccurrence and progression of disease', 'Secondary prevention', 'Socioeconomic determinants', 'cardiologists', 'community'], ['Lipoprotein (A)', 'high CVD risk and positive family history of early CVD.'], ['Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID)', 'studies [44]'], ['Loss of NO', 'endothelial cell senescence'], ['Low risk individuals', 'evaluate for each individual the total ten-year risk of death by sex, smoking, age, systolic blood pressure and total cholesterol.', 'total cholesterol'], ['Low-income and middle-income countries', 'Prevalence of hypertension'], ['Lyon Heart Study', 'cardiovascular disease events and death'], ['Malawi and Uganda', 'illustrative examples'], ['Matthew S Freiberg Prof, MD', 'Vanderbilt University Medical Center, Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA'], ['Mediterranean population', 'high vegetable-fat intake'], ['Meta-analysis', 'Systematic review'], ['Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H', 'Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western'], ['Modern cardiovascular risk management in clinical practice', 'Volpe M, Calivieri C, Alonzo A'], ['Monitoring', 'several levels'], ['Morbidity and Mortality', 'Whole Grain Foods High in Fiber'], ['Moyer V A', 'U.S. Preventive Services Task Force', 'recommended the use of low-dose aspirin'], ['Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC', 'Trans fatty-acids and cardiovascular disease. N Engl J Med 2006; 354: 1601-13.'], ['MultipIe Risk Factor Intervention Trial Research Group', 'Multiple Risk Factor Intervention Trial'], ['Multiple risk factors', 'multiply CVD risk'], ['N Engl J Med 2017; 377: 1119–31', 'antiinflammatory therapy with canakinumab for atherosclerotic disease'], ['NAD', 'nicotinamide adenine dinucleotide'], ['NAD and nicotinamide phosphoribosyltransferase (Nampt)', 'activity'], ['NAD synthesis enzyme Pnc1 (yeast homolog of Nampt)', 'activating sirtuin proteins'], ['NADPH', 'reduced nicotinamide adenine dinucleotide phosphate'], ['Nampt', 'nicotinamide phosphoribosyltransferase'], ['National Consolidated HIV Guidelines (2015)', 'South African dyslipidaemia guideline (2018)'], ['National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)', 'Study conducted by the same organization'], ['Neurology 2011; 76: 444–50', '[PubMed: 21248273]'], ['Nonterah EA, Boua PR, Klipstein-Grobusch K, et al.', 'PubMed: 31011634'], ['Nordmann A', 'Suter-Zimmermann K'], ['Nutr. 2001; 55(8):636–42', '[PubMed: 11477461]'], ['Nuts', 'ROS and lipid profiles; improves BP and endothelial function'], ['Okinawans eat a moderately restricted diet', 'data from human studies'], ['Online', 'Online Refrencing', 'Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). [13]', 'http://www.revespcardiol. org/eu/global-preventive-policies-strategies-at/articulo/13125894 (accessed 12 September 2016). [12]'], ['Online referencing', 'http://eurheartj.oxfordjournals.org/September 16,2016'], ['Origasa H', 'Yokoyama M'], ['P, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Eur Heart J 2011; 32: 1345-61.', 'evidence and guidance for management'], ['PAD: peripheral arterial disease', 'includes stroke or transient ischemic attack'], ['PI3K', 'phosphatidylinositol-3-kinase'], ['PMC 2016 March 01', 'available in'], ['PNC1', 'pyrazinamidase and nicotinamidase 1'], ['PREDIMED', 'low Mediterranean diet'], ['PREDIMED randomized trial', 'one-year results'], ['Page 14', 'Widmer et al'], ['Pathology of radiation-induced heart disease', 'radiation-induced heart disease'], ['Patients with acute coronary syndrome', 'Percutaneous coronary intervention'], ['People aged 15 years and older', 'Prevalence of tobacco smoking'], ['Pfeffer MA', 'Sacks FM, Moyé LA, et al'], ['Physician’s Health Study published in 1995', 'largest cohort trials examining fish intake and cardiovascular disease'], ['Population approach', 'clinical approach'], ['Pre-eclampsia', 'cardiovascular disease and cancer'], ['Prof Priscilla Hsue, MD', 'University of California, San Francisco, CA, USA'], ['PubMed: 12571649', 'PubMed: 19364995'], ['PubMed: 20433126', 'Source of information'], ['PubMed: 20806105', 'Thromb Haemost. 2010; 104(4):664–80'], ['Publication Journal and Volume', 'eNeurologicalSci 2019; 15: 100189'], ['QRISK2', 'Quality Cardiovascular Risk Score 2'], ['RCT data regarding a reduction in cardiovascular disease morbidity or mortality', 'recommendation promoting whole grains'], ['RCT, outcomes-based data', 'wide array'], ['REPRIEVE, SEARCH, and EVERLAST48', 'results of studies'], ['ROS production', 'free radical– imposed damage'], ['Reducing the risk of coronary events', 'Scandinavian Simvastatin Survival Study (4S)', 'studies [43]'], ['Reduction of CVD morbidity and mortality', 'goal of clinical and population preventative strategies'], ['Research in', 'implementation of'], ['Research to understand the disparity in heart failure outcomes for people with HIV', 'Screening of individuals at greatest risk for heart failure62'], ['Researcher', 'de Lorgeril M'], ['Risk assessment algorithm Yes', 'diagnostic criteria, risk assessment algorithm, and management algorithm'], ['SCORE tables', 'people without known CVD'], ['SIR2', 'silent information regulator 2'], ['Seguimiento Universidad de Navarra (SUN) Study', 'population with a high vegetable-fat intake'], ['Sinclair', 'on.North'], ['South African guidelines', 'management of ischaemic stroke and transient'], ['Soy food consumption', 'Soy isoflavones', 'lower risk of coronary heart disease', 'normocholesterolemic and mildly hypercholesterolemic postmenopausal women', 'plasma lipids'], ['Stratification of CVD risk', 'people who do not yet have manifest atherosclerotic disease but can develop CVD'], ['T cells in the gut mucosa', 'damages the lining of the gut'], ['TG >2.3 mmol/l', 'cannot be reduced by changing lifestyle'], ['TOR', 'survival', 'target of rapamycin'], ['Target of Rapamycin/Rapamycin', 'bacterial product rapamycin', 'insulin and growth factors', 'intracellular amino acid levels', 'pacemaker under stress', 'serine-threonine protein kinase', 'sinoatrial node'], ['The American Heart Association (AHA)', 'guidance'], ['The decision on treatment strategy depends on', 'treatment strategy'], ['The effect of these factors', 'cholesterol, smoking status and systolic pressure'], ['The ratio APO B/APO A', 'alternative to the probing.'], ['The ratio of non HDL C / HDL C', 'alternative in'], ['Their management', 'Variable cardiovascular risk factors'], ['Total CVD risk', 'individual is likely to develop a fatal cardiovascular event for a certain period of time'], ['Total ten-year risk of death', 'by sex, smoking, age, systolic blood pressure and total cholesterol'], ['Triglyceride-rich lipoproteins', 'high-density lipoprotein cholesterol'], ['VEGF', 'vascular endothelial growth factor'], ['Web version on PubMed Central', 'supplementary material'], ['Women’s interagency HIV study', 'adherence to antiretroviral therapy', 'human immunodeficiency virus', 'lipid lowering', 'nonlipid cardiovascular disease risk factor management', 'race, ethnicity, HIV status', 'statin utilization', 'uninfected persons'], ['abnormal', 'yes'], ['abnormalities leading to arrhythmias', 'altered conduction system'], ['about these risk factors is suboptimal at this time', 'current state of knowledge and awareness'], ['absence of cost-effective data on routine coronary heart disease risk factor screening', 'few resources'], ['absorption of fats, simple carbohydrates, or toxins', 'high-fiber whole grain diets'], ['acknowledgments', \"investigator's work\"], ['activation of AMPK by metformin', 'reduces pressure overload–induced cardiac hypertrophy'], ['acute, episodic care', 'chronic care programmes'], ['advocacy', 'research'], ['affecting endothelium-dependent dilation', 'endothelial cell function'], ['after a stroke', 'other targeted therapies'], ['after third trimester of pregnancy', 'normal glucose metabolism'], ['age and gender', 'invariable risk factors', 'men over age 45 and women over 55 years'], ['age and other factors', 'heart rate'], ['age-related macular degeneration', 'vasculature undergoes'], ['aged 65 or older', 'population'], ['ageing population', 'increasing disease to mortality'], ['aggregate', 'dietary pattern', 'individual constituents'], ['aggressive treatment for many modifiable CAD risk factors', 'appropriate glycemic control', 'risk of all-cause mortality', 'twice the excess risk of fatal and nonfatal vascular events', 'women with DM'], ['aging and cardiovascular fields', 'low calorie diet combined with exercise'], ['aging heart', 'decrease in heart rate variability and maximum heart rate', 'decrease in the number and function of sinoatrial nodal pacemaker cells', 'increase in conduction abnormalities'], ['aging models', 'assessed for alterations in cardiac conduction'], ['aging results', 'vasculature'], ['aging study cohort', 'measure longitudinally'], ['alternative mechanisms', 'proposed (67)'], ['and left ventricular hypertrophy', 'myocardial fibrosis'], ['annually', 'baseline'], ['antihypertensive agents', 'sex-specific analysis'], ['antioxidants', 'hydroxytyrosol'], ['antiplatelet therapy', 'secondary preventive agent'], ['antiretroviral drugs', 'psychotropic drugs'], ['appears to be improving over time', 'modification of risk factors such as hypertension'], ['approaches to reduce ischaemic heart', 'scarcity of data on sudden cardiac death in HIV'], ['appropriate LDL C target values', 'patient category'], ['appropriate risk stratification', 'women compared to men'], ['areas to investigate', 'research areas'], ['arterial hypertension (AH)', 'more than 30% of adults', 'most important independent risk factor of CVD', 'most important preventable factors of premature mortality in the world', 'one quarter of the adult population', 'persistent blood pressure 140/90 mmHg and above', 'risk factor of CVD, but also mortality from coronary illness or', 'suffer from AH in most developed countries'], ['arterial thickening and stiffness', 'clinical changes'], ['aspirin therapy', 'higher bleeding risk'], ['associations', 'clinical studies'], ['atherogenic lipid and cholesterol profiles', 'cholesterol metabolism'], ['atherosclerotic cardiovascular disease risk', 'smoking cessation and reduction'], ['attrition', 'degeneration of stem and progenitor cell compartments'], ['augmenting age-related cardiac decline', 'role of telomere attrition'], ['avoid pregnancy', 'contraceptive use'], ['barriers to scale up and expand', 'practical approach'], ['beneficial effect', 'isocaloric nut consumption'], ['beneficial effects', 'effects', 'mimic'], ['benefit', 'lower thresholds for lipid, blood pressure, or glucose control'], ['benefit in terms of lipid profiles', 'smaller RCTs'], ['benefit of increased fiber intake', 'large cohort studies and meta-'], ['benefits extend to improved glucose metabolism', 'reduction in weight'], ['beta blockers', 'thiazides'], ['biomarkers of aging', 'used'], ['biosynthesis of ubiquinone (coenzyme Q)', 'electron transporter'], ['blockers (ARBs)', 'losartan and irbesartan'], ['blocking', 'mTOR control of protein translation and cell size'], ['blood lipids', 'reduced'], ['blood pressure, cholesterol, markers of inflammation', 'cardiovascular disease health'], ['blood pressure, lipids, fasting blood glucose, body mass index', 'yearly assessment'], ['both', 'strong trend'], ['brain', 'periphery'], ['butter- and walnut-rich meals', 'olive oil-rich meal'], ['calcification', 'vascular alterations'], ['caloric intake reduction', \"rat's lifespan extension\"], ['calorie restriction (CR)', 'lifespan-extending properties'], ['cardiac aging', 'pathways regulated by growth factors in cardiomyocytes'], ['cardiac hypertrophy mediated by pressure overload', 'inhibition of mTOR signaling'], ['cardiac mortality', 'postoperative radiation therapy'], ['cardiologists in outpatient practice', 'family medicine practitioners and general internists'], ['cardioprotective strategies', 'ω-3 fatty acids'], ['cardiovascular development, function, disease', 'role of transcription factors'], ['cardiovascular disease in high-risk groups', 'primary and secondary prevention'], ['cardiovascular disease morbidity and mortality impact', 'moderate nut consumption'], ['cardiovascular disease risk prediction for people with HIV', 'important incidence and risk factor data'], ['cardiovascular disease surrogate markers', 'control, intermediate whole grain, high whole grain diets', 'normal carbohydrate intake', 'overweight individuals'], ['cardiovascular health among men and women', 'pathophysiological basis'], ['cardiovascular health in humans', 'polyphenols'], ['cardiovascular risk management', 'people living with HIV in Europe'], ['care delivery since 2006', 'heart failure diagnosis'], ['carotid intima-media thickness (CIMT)/plaque information on a carotid ultrasound', 'risk prediction for CVD'], ['carotid ultrasound and coronary computed tomography (CT)', 'imaging'], ['cell size and growth', 'protein synthesis'], ['cellular and tissue levels', 'functional consequences'], ['centred around stroke units where', 'stroke diagnostic and treatment pathways'], ['cerebrovascular accident', 'current guidelines'], ['changes in cardiovascular disease mortality for people with HIV', 'difficult given concomitant changes'], ['changing one or following a few dietary constituents', 'detrimental effects'], ['characterize signaling pathways activated in response to loss of telomeric DNA', 'p53/mitochondrial signaling pathway'], ['cholesterol lowering drugs', 'drugs'], ['cholesterol reduction', 'coronary events'], ['cited work', 'space limitations'], ['clinical trial data', 'observational data on heart failure'], ['cognitive decline', 'erectile dysfunction'], ['combat cardiovascular disease', 'understanding mechanisms'], ['combination of risk factors and HIV infection', 'subclinical atherosclerosis'], ['communication from the mitochondria to the nucleus', 'role of retrograde mitochondrial signaling'], ['comorbid burden of cardiovascular disease and HIV', 'regions'], ['comprehensive care for HIV-infected patients', 'statin prescribing practices'], ['comprehensive understanding', 'conflict of interest disclosure', 'coronary interventions', 'female patients', 'gender-specific care', 'hormonal and genomic basis', 'overall risk', 'personalized medicine', 'postmenopausal women and men', 'research participation by women'], ['concomitant weight loss', 'effects of nitric oxide species'], ['concrete cardiovascular disease endpoints', 'randomized trials or observational studies'], ['conflicting results', 'limited direct mouse studies', 'various inbred and outbred strains of mice and wild mice'], ['conservation', 'pathway in higher organisms'], ['contextually appropriate innovations', 'people with HIV at high risk for coronary heart disease'], ['controlling heart rate', 'loss of cells in the sinoatrial node'], ['coronary heart disease risk factor screening', 'routine care for people with HIV'], ['coronary heart disease risk reduction', 'models for integrating HIV care', 'outcomes in general'], ['coronary patients with low clinical risk', 'moderately or intensively exercise'], ['country-level HIV programmes', 'traditionally focused health systems'], ['cross-sectional study', 'increased fruit and vegetable intake'], ['cultured cardiomyocytes', 'in vivo'], ['current approaches', 'reducing cardiovascular disease risk and their effectiveness'], ['cyclosporine', 'isotretinoin'], ['data acquisition', 'data analysis and interpretation'], ['decrease in heart rate variability', 'maximum heart rate'], ['decreased cardiac output', 'increase in fibrotic tissue'], ['decreasing incidence of sudden cardiac death', 'ischaemic heart disease'], ['depressed women', 'higher risk for CVD'], ['depressive disorders', 'incident'], ['developing stroke diagnostic and treatment pathways', 'priority should be given to'], ['development of tools', 'genetic biomarkers, serum biomarkers, imaging such as carotid ultrasound and coronary computed tomography (CT)', 'risk stratification'], ['diagnose common presentations of heart failure', 'echocardiography skills'], ['diagnosis and treatment', 'peripheral arterial diseases'], ['diagnosis, monitoring and treatment', 'variable risk factors'], ['dietary fiber intake', 'whole grains consumption'], ['difficult to sustain', 'high intensities'], ['diminishes cardiac function', 'echocardiography', 'histological analysis of heart', 'hypertrophy', 'measure LV size', 'measure alterations in cardiac size and functional parameters', 'measured with a variety of techniques', 'physiological (reversible) or pathological (irreversible)', 'result of increase in size of individual cardiomyocytes', 'surface ECG analysis', 'technique for measuring hypertrophy', 'ventricular hypertrophy'], ['disease in patients with already proven CVD', 'reoccurrence'], ['documented at each clinic visit', 'potential drug–drug interactions'], ['dose aspirin', 'risk of stroke'], ['drug sequencing algorithm', 'extensive risk assessment algorithm'], ['duration', 'intensity'], ['eNOS', 'endothelial nitric oxide synthetase'], ['eNOS activity', 'hemodynamic shear stress'], ['early diagnosis', 'pharmacotherapy in most cases'], ['effect on glycemic control', 'glycaemic response'], ['effects of IGF-1 on cardiac stem cell', 'myocardial regeneration'], ['efficiency', 'testing new deployments of existing resources'], ['efforts to reduce smoking', 'peripheral artery disease incidence and progression'], ['efforts toward those who will be most likely to bene-fit', 'reassurance and avoidance of side ef-fects in lower-risk persons who will derive less benefit'], ['electrophysiology (EP) studies', 'testing aging models for alterations in EP parameters'], ['elevated APOB', 'elevated lipoproteins'], ['elevated CRP', 'glucose intolerance'], ['elevated fibrogen', 'elevated homocysteine'], ['endothelial cells', 'proliferate and migrate'], ['endothelial progenitor cell numbers', 'marker of increased endothelial repair'], ['enrollment', 'other possible barriers to the recruitment of women', 'recruitment for CV clinical trials is performed', 'reduced referrals to cardiology practices', 'underestimated cardiac risk in women and atypical cardiac disease presentation', 'women manifest CVD later in life, and an age-gender bias may be present during the study enrollment process'], ['episodic', 'life-long commitment'], ['eradication', 'macrophages'], ['estimated risk >5%', 'those with an estimated risk >5%'], ['estimated risk of CVD', 'risk assessment of CVD'], ['estrogens', 'tamoxifen'], ['everyday practice of family practitioners and cardiologists', 'incorporate in'], ['evidence gaps', 'lessons learned'], ['exacerbated myocardial infarction', 'mouse models using dominant-negative AMPK'], ['exact measures for each variable risk factor', 'informative papers'], ['existing HIV-care delivery', 'feasibility of models'], ['expenditure in the absence of exercise', 'obesity and glucose homeostasis'], ['exposure to coronary heart disease', 'policy interventions for people with HIV'], ['extensive evidence', 'supporting the concepts'], ['fear and distrust', 'financial costs', 'interference with work or family responsibilities', 'lack of knowledge', 'lack of transportation', 'participation in research', 'preserving cardiovascular health in women', 'preventive therapies for CVD', 'reducing mortality', 'research enterprise', 'study participation', 'subject burden'], ['feasible approach', 'improve linkage and retention in care'], ['fibrate, nia-cin, niacin + laropiprant, omega 3 fatty acid, statin + nicotinic acid', 'should be given'], ['finding ways', 'pharmacological agents'], ['first part', 'series'], ['followed up 8762 people with HIV since 2000', 'study in Europe'], ['functional recovery', 'socioeconomic status'], ['future', 'nontraditional risk factors and markers'], ['genetic biomarkers', 'serum biomarkers'], ['geographical distribution', 'variability'], ['good cardiac health', 'relative risk of acute myocardial infarction'], ['governmental and non-governmental organizations', 'improving the lifestyle of individuals and the entire community'], ['group benefited', 'women > 65 years old'], ['guidance on the safety and effectiveness', 'high-quality studies'], ['guidelines tailored for So-Armah et al.', 'insufficient cardiovascular disease risk stratification tools'], ['gut permeability', 'microbial translocation products'], ['haemorrhagic stroke', 'rest of strokes in people with HIV'], ['heart disease risk', 'whole grain foods'], ['heart failure medication', 'providers'], ['high legume intake', 'randomization'], ['high-dose volumes', 'increased mortality'], ['high-isoflavone soyfoods', 'low-isoflavone soyfoods'], ['higher peripheral artery disease prevalence', 'study from Nigeria'], ['highly dividing tissues', 'loss of telomeres'], ['highly proven and advertised interventions', 'reductions in cardiovascular disease burden'], ['historical and narrative review', 'professional society guidelines'], ['history of recurrent preeclampsia', 'preeclampsia with preterm birth'], ['history of recurrent preeclampsia or preeclampsia with preterm birth', 'more aggressive screening'], ['hiv-infected persons', 'noncommunicable diseases'], ['hypertrophic cardiomyopathy', 'ventricular preexcitation'], ['hypocaloric refined grains', 'hypocaloric whole grains'], ['identified a spectrum of risk factors for cardiovascular diseases specific to women', 'scientific progress in the past decade'], ['identifying the role of coronary heart disease risk-factor management', 'in temporal changes in cardiovascular disease mortality for people with HIV'], ['immunopathogenesis', 'investigating'], ['impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events', 'traditional and novel risk factors'], ['implantable cardiac defibrillator', 'sarcoidosis'], ['improving cardiovascular morbidity and mortality', 'reducing blood pressure'], ['improving vascular function', 'reducing ROS'], ['in aged models', 'measuring arterial thickness and stiffness'], ['in sub-Saharan Africa and low-income and middle-income countries', 'large HIV-population cohorts'], ['incidence of avoidable amputations', 'late disease presentation'], ['including cardiomyopathy', 'structural heart disease'], ['increase awareness', 'routine ankle-brachial index screening'], ['increased consumption of fruits and vegetables', 'reduction in cardiovascular disease surrogates'], ['increased fiber from whole grains', 'whole-body benefits'], ['increased fish consumption', 'reduced cardiovascular disease mortality'], ['increased risk for developing CVD', 'monitoring models'], ['increasing arterial contraction', 'to sustain stroke volume and workload'], ['increasing average lifespan of humans', 'next 20 years'], ['individual risk factors', 'recognizing individual risk factors'], [\"individual's risk assessment\", 'risk assessment'], ['infected monocytes', 'peripheral circulation'], ['inherited syndrome of', 'mutations in the regulatory γ2 subunit of AMPK'], ['inherited-positive family history', 'menopause in women'], ['inhibition in the heart', 'mTOR signaling'], ['intracranial', 'large to medium sized ischaemic strokes'], ['investigators', 'work'], ['ischaemic strokes', 'non-traditional vascular risk factors'], ['life-preserving effects', 'reducing HIV viraemia'], ['lifestyle changes or pharmacotherapy', 'specific blood pressure thresholds'], ['lifestyle habits', 'political activities'], ['lipid or blood pressure profiles', 'no significant change'], ['little to no change', 'small RCTs in low-moderate risk patients'], ['longitudinal studies in aging cohorts', 'surface ECGs'], ['low nadir', 'specific HIV-related factors'], ['luminal enlargement', 'structure and function alterations with age'], ['manage heart failure', 'tailored algorithms'], ['management of patients with ventricular arrhythmias', 'prevention of sudden cardiac death'], ['markers of inflammation', 'primary cardiovascular disease outcomes'], ['microbial translocation process', 'portal circulation'], ['molecular mechanism', 'triggering cause'], ['monocytes', 'postprandial activation of NF-kB pathway'], ['more aggressive consideration', 'screening and lifestyle modification'], ['much of the effort', 'reduce coronary heart disease risk in low-income and middle-income countries'], ['murine models', 'reduced mitochondria ROS'], ['nemotode Caenorhabditis elegans and fly Drosophila malanogaster', 'yeast Saccharomyces cerevisiae'], ['new concept', 'seminal observation by McCay et al in 1935'], ['no HIV-specific', 'risk score'], ['no benefit of soy', 'on NO bioavailability or BP in moderately hypertensive, post-menopausal women ( 95)'], ['no vascular disease', 'vascular disease'], ['non-communicable disease screening', 'population-based integrated HIV screening'], ['numerous cohort studies', 'quite a few'], ['nut consumption', 'preventative risk reduction on heart disease'], ['nuts and legumes', 'positive effect'], ['offer life-saving and disability-saving therapy', 'rapid patient assessment'], ['oleuropein', 'potent antioxidants'], ['omega-3 fatty acid', 'sudden cardiac death prevention'], ['on sudden cardiac death in HIV', 'scant data'], ['pathway to care', 'people with HIV who screen positive for'], ['patient frequency', 'pulse monitor'], ['patients with rheumatoid arthritis', 'rheumatoid arthritis'], ['people with HIV older than 40 years', 'routine screening'], ['pharmacotherapy', 'start low, go slow strategy'], ['positive influence of CR and resveratrol in CVD', 'sirtuin proteins'], ['postmenopausal CVD', 'women and CVD'], ['preexisting cardiac risk factors', 'radiotherapy'], ['prevention of cardiovascular disease development', 'variable cardiovascular risk factors'], ['preventive strategy', 'symptom identification'], ['previously discussed limitations', 'reasonable'], ['primary outcomes', 'supplementation'], ['progress', 'reduce stroke burden in general population'], ['proportion of whole or cracked grain', 'wholemeal breads'], ['prospective Chicago Western Electric Study', 'red meat intake'], ['protective NO', 'shear stress'], ['published in 2004', 'results of INTERHEART'], ['reactive oxidation', 'reduced inflammation'], ['reduced blood flow', 'vessels age'], ['reduction in cardiovascular disease events', 'three to five servings of fruits and vegetables daily'], ['refined carbohydrates', 'whole grains +/− whole'], ['relative risk esti-mation', 'young person'], ['replacing', 'walnuts, peanuts, almonds'], ['review', 'role and molecular mechanisms regulating oxidative stress'], ['risk and benefits', 'weighed'], ['risk awareness for coronary heart disease among treated people with HIV', 'surveillance efforts'], ['risk reduction strategies', 'stroke in people with HIV'], ['role various longevity genes influence', 'vasculature aging'], ['similarity in treatment recommendation', 'uncertainty about the mechanisms of heart failure in HIV'], ['source of discrepancies', 'well-controlled confounders in fish oil supplementation RCTs'], ['statistically significant effect', 'subsequent RCT'], ['suppressor of SNF1 protein 2/4', 'transcriptional induction'], ['tailored risk scores for stroke prevention', 'using HIV-population cohorts'], ['to stimulus', 'variable cardiovascular responses'], ['untreated HIV patients', 'vascular unit']]\n"
     ]
    }
   ],
   "source": [
    "communities_generator = nx.community.girvan_newman(G)\n",
    "top_level_communities = next(communities_generator)\n",
    "next_level_communities = next(communities_generator)\n",
    "communities = sorted(map(sorted, next_level_communities))\n",
    "print(\"Number of Communities = \", len(communities))\n",
    "print(communities)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Create a dataframe for community colors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>node</th>\n",
       "      <th>color</th>\n",
       "      <th>group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Omega-3 fatty acids in high-risk cardiovascul...</td>\n",
       "      <td>#57db94</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Filion K, El Khoury F, Bielinski M, Schiller I...</td>\n",
       "      <td>#57db94</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>marine n-3 fatty acids, fish intake, and the ...</td>\n",
       "      <td>#8d57db</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(1·69–2·63)</td>\n",
       "      <td>#8d57db</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(95% CI)</td>\n",
       "      <td>#8d57db</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4586</th>\n",
       "      <td>using HIV-population cohorts</td>\n",
       "      <td>#db577c</td>\n",
       "      <td>684</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4587</th>\n",
       "      <td>to stimulus</td>\n",
       "      <td>#d5db57</td>\n",
       "      <td>685</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4588</th>\n",
       "      <td>variable cardiovascular responses</td>\n",
       "      <td>#d5db57</td>\n",
       "      <td>685</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4589</th>\n",
       "      <td>untreated HIV patients</td>\n",
       "      <td>#57db61</td>\n",
       "      <td>686</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4590</th>\n",
       "      <td>vascular unit</td>\n",
       "      <td>#57db61</td>\n",
       "      <td>686</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4591 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   node    color  group\n",
       "0      Omega-3 fatty acids in high-risk cardiovascul...  #57db94      1\n",
       "1     Filion K, El Khoury F, Bielinski M, Schiller I...  #57db94      1\n",
       "2      marine n-3 fatty acids, fish intake, and the ...  #8d57db      2\n",
       "3                                           (1·69–2·63)  #8d57db      2\n",
       "4                                              (95% CI)  #8d57db      2\n",
       "...                                                 ...      ...    ...\n",
       "4586                       using HIV-population cohorts  #db577c    684\n",
       "4587                                        to stimulus  #d5db57    685\n",
       "4588                  variable cardiovascular responses  #d5db57    685\n",
       "4589                             untreated HIV patients  #57db61    686\n",
       "4590                                      vascular unit  #57db61    686\n",
       "\n",
       "[4591 rows x 3 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "palette = \"hls\"\n",
    "\n",
    "## Now add these colors to communities and make another dataframe\n",
    "def colors2Community(communities) -> pd.DataFrame:\n",
    "    ## Define a color palette\n",
    "    p = sns.color_palette(palette, len(communities)).as_hex()\n",
    "    random.shuffle(p)\n",
    "    rows = []\n",
    "    group = 0\n",
    "    for community in communities:\n",
    "        color = p.pop()\n",
    "        group += 1\n",
    "        for node in community:\n",
    "            rows += [{\"node\": node, \"color\": color, \"group\": group}]\n",
    "    df_colors = pd.DataFrame(rows)\n",
    "    return df_colors\n",
    "\n",
    "\n",
    "colors = colors2Community(communities)\n",
    "colors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Add colors to the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "for index, row in colors.iterrows():\n",
    "    G.nodes[row['node']]['group'] = row['group']\n",
    "    G.nodes[row['node']]['color'] = row['color']\n",
    "    G.nodes[row['node']]['size'] = G.degree[row['node']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "./docs/index.html\n"
     ]
    }
   ],
   "source": [
    "from pyvis.network import Network\n",
    "\n",
    "graph_output_directory = \"./docs/index.html\"\n",
    "\n",
    "net = Network(\n",
    "    notebook=False,\n",
    "    # bgcolor=\"#1a1a1a\",\n",
    "    cdn_resources=\"remote\",\n",
    "    height=\"900px\",\n",
    "    width=\"100%\",\n",
    "    select_menu=True,\n",
    "    # font_color=\"#cccccc\",\n",
    "    filter_menu=False,\n",
    ")\n",
    "\n",
    "net.from_nx(G)\n",
    "# net.repulsion(node_distance=150, spring_length=400)\n",
    "net.force_atlas_2based(central_gravity=0.015, gravity=-31)\n",
    "# net.barnes_hut(gravity=-18100, central_gravity=5.05, spring_length=380)\n",
    "net.show_buttons(filter_=[\"physics\"])\n",
    "\n",
    "net.show(graph_output_directory, notebook=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
